-
1
-
-
0031914321
-
Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2
-
Agrawal, B., Krantz, M.J., Reddish, M.A. Longenecker, B.M. (1998) Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2. Nature Medicine, 4, 43 49.
-
(1998)
Nature Medicine
, vol.4
, pp. 43-49
-
-
Agrawal, B.1
Krantz, M.J.2
Reddish, M.A.3
Longenecker, B.M.4
-
2
-
-
33846871255
-
Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation
-
Atanackovic, D., Arfsten, J., Cao, Y., Gnjatic, S., Schnieders, F., Bartels, K., Schilling, G., Faltz, C., Wolschke, C., Dierlamm, J., Ritter, G., Eiermann, T., Hossfeld, D.K., Zander, A.R., Jungbluth, A.A., Old, L.J., Bokemeyer, C. Kröger, N. (2007) Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation. Blood, 109, 1103 1112.
-
(2007)
Blood
, vol.109
, pp. 1103-1112
-
-
Atanackovic, D.1
Arfsten, J.2
Cao, Y.3
Gnjatic, S.4
Schnieders, F.5
Bartels, K.6
Schilling, G.7
Faltz, C.8
Wolschke, C.9
Dierlamm, J.10
Ritter, G.11
Eiermann, T.12
Hossfeld, D.K.13
Zander, A.R.14
Jungbluth, A.A.15
Old, L.J.16
Bokemeyer, C.17
Kröger, N.18
-
3
-
-
24944459890
-
Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4
-
Attia, P., Phan, G.Q., Maker, A.V., Robinson, M.R., Quezado, M.M., Yang, J.C., Sherry, R.M., Topalian, S.L., Kammula, U.S., Royal, R.E., Restifo, N.P., Haworth, L.R., Levy, C., Mavoroukakis, S.A., Nichol, G., Yellin, M.J. Rosenberg, S.A. (2005) Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4. Journal of Clinical Oncology, 23, 6043 6053.
-
(2005)
Journal of Clinical Oncology
, vol.23
, pp. 6043-6053
-
-
Attia, P.1
Phan, G.Q.2
Maker, A.V.3
Robinson, M.R.4
Quezado, M.M.5
Yang, J.C.6
Sherry, R.M.7
Topalian, S.L.8
Kammula, U.S.9
Royal, R.E.10
Restifo, N.P.11
Haworth, L.R.12
Levy, C.13
Mavoroukakis, S.A.14
Nichol, G.15
Yellin, M.J.16
Rosenberg, S.A.17
-
4
-
-
33644829447
-
Early mortality after diagnosis of multiple myeloma: Analysis of patients entered onto the United kingdom Medical Research Council trials between 1980 and 2002-Medical Research Council Adult Leukaemia Working Party
-
Augustson, B.M., Begum, G., Dunn, J.A., Barth, N.J., Davies, F., Morgan, G., Behrens, J., Smith, A., Child, J.A. Drayson, M.T. (2005) Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United kingdom Medical Research Council trials between 1980 and 2002-Medical Research Council Adult Leukaemia Working Party. Journal of Clinical Oncology, 23, 9219 9226.
-
(2005)
Journal of Clinical Oncology
, vol.23
, pp. 9219-9226
-
-
Augustson, B.M.1
Begum, G.2
Dunn, J.A.3
Barth, N.J.4
Davies, F.5
Morgan, G.6
Behrens, J.7
Smith, A.8
Child, J.A.9
Drayson, M.T.10
-
5
-
-
0028246112
-
Evidence that the clonogenic cell in multiple myeloma originates from a pre-switched but somatically mutated B cell
-
Bakkus, M.H.C., Van Riet, I., Van Camp, B. Thielemann, K. (1994) Evidence that the clonogenic cell in multiple myeloma originates from a pre-switched but somatically mutated B cell. British Journal of Haematology, 87, 68 74.
-
(1994)
British Journal of Haematology
, vol.87
, pp. 68-74
-
-
Bakkus, M.H.C.1
Van Riet, I.2
Van Camp, B.3
Thielemann, K.4
-
6
-
-
33750614944
-
Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after DC injection of cytokine matured DCs in myeloma patients
-
Banerjee, D., Dhodapkar, M.V., Matayeva, E., Steinman, R.M. Dhodapkar, K. (2006) Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after DC injection of cytokine matured DCs in myeloma patients. Blood, 108, 2655 2661.
-
(2006)
Blood
, vol.108
, pp. 2655-2661
-
-
Banerjee, D.1
Dhodapkar, M.V.2
Matayeva, E.3
Steinman, R.M.4
Dhodapkar, K.5
-
7
-
-
1942534043
-
The evolution of thalidomide and its IMiD derivatives as anticancer agents
-
Bartlett, J.B., Dredge, K. Dalgleish, A.G. (2004a) The evolution of thalidomide and its IMiD derivatives as anticancer agents. Nature Reviews Cancer, 4, 314 322.
-
(2004)
Nature Reviews Cancer
, vol.4
, pp. 314-322
-
-
Bartlett, J.B.1
Dredge, K.2
Dalgleish, A.G.3
-
8
-
-
11144355748
-
Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers
-
Bartlett, J.B., Michael, A., Clarke, I.A., Dredge, K., Nicholson, S., Kristeleit, H., Polychronis, A., Pandha, H., Muller, G.W., Stirling, D.I., Zeldis, J. Dalgleish, A.G. (2004b) Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers. British Journal of Cancer, 90, 955 961.
-
(2004)
British Journal of Cancer
, vol.90
, pp. 955-961
-
-
Bartlett, J.B.1
Michael, A.2
Clarke, I.A.3
Dredge, K.4
Nicholson, S.5
Kristeleit, H.6
Polychronis, A.7
Pandha, H.8
Muller, G.W.9
Stirling, D.I.10
Zeldis, J.11
Dalgleish, A.G.12
-
9
-
-
27544514423
-
Protein transduction of dendritic cells for NY-ESO-1-based immunotherapy of myeloma
-
Batchu, R.B., Moreno, A.M., Szmania, S.M., Bennett, G., Spagnoli, G.C., Ponnazhagan, S., Barlogie, B., Tricot, G. van Rhee, F. (2005) Protein transduction of dendritic cells for NY-ESO-1-based immunotherapy of myeloma. Cancer Research, 65, 10041 10049.
-
(2005)
Cancer Research
, vol.65
, pp. 10041-10049
-
-
Batchu, R.B.1
Moreno, A.M.2
Szmania, S.M.3
Bennett, G.4
Spagnoli, G.C.5
Ponnazhagan, S.6
Barlogie, B.7
Tricot, G.8
Van Rhee, F.9
-
10
-
-
30844450344
-
Combined vaccination with idiotype-pulsed allogeneic dendritic cells and soluble protein idiotype for multiple myeloma patients relapsing after reduced-intensity conditioning allogeneic stem cell transplantation
-
Bendandi, M., Rodriguez-Calvillo, M., Inoges, S., Lopez-Diaz de Cerio, A., Perez-Simon, J.A., Rodriguez-Caballero, A., Garcia-Montero, A., Almeida, J., Zabalegui, N., Giraldo, P., San Miguel, J. Orfao, A. (2006) Combined vaccination with idiotype-pulsed allogeneic dendritic cells and soluble protein idiotype for multiple myeloma patients relapsing after reduced-intensity conditioning allogeneic stem cell transplantation. Leukaemia Lymphoma, 47, 29 37.
-
(2006)
Leukaemia Lymphoma
, vol.47
, pp. 29-37
-
-
Bendandi, M.1
Rodriguez-Calvillo, M.2
Inoges, S.3
Lopez-Diaz De Cerio, A.4
Perez-Simon, J.A.5
Rodriguez-Caballero, A.6
Garcia-Montero, A.7
Almeida, J.8
Zabalegui, N.9
Giraldo, P.10
San Miguel, J.11
Orfao, A.12
-
11
-
-
0029983701
-
Modulation of anti-idiotypic immune response by immunization with the autologous M-component protein in multiple myeloma patients
-
Bergenbrant, S., Yi, Q., Osterborg, A., Bjorkholm, M., Osby, E., Mellstedt, H., Lefvert, A.K. Holm, G. (1996) Modulation of anti-idiotypic immune response by immunization with the autologous M-component protein in multiple myeloma patients. British Journal of Haematology, 92, 840 846.
-
(1996)
British Journal of Haematology
, vol.92
, pp. 840-846
-
-
Bergenbrant, S.1
Yi, Q.2
Osterborg, A.3
Bjorkholm, M.4
Osby, E.5
Mellstedt, H.6
Lefvert, A.K.7
Holm, G.8
-
12
-
-
27244445489
-
Molecular pathogenesis and a consequent classification of multiple myeloma
-
Bergsagel, P.L. Kuehl, W.M. (2005) Molecular pathogenesis and a consequent classification of multiple myeloma. Journal of Clinical Oncology, 23, 6333 6338.
-
(2005)
Journal of Clinical Oncology
, vol.23
, pp. 6333-6338
-
-
Bergsagel, P.L.1
Kuehl, W.M.2
-
13
-
-
33646577466
-
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
-
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T.B., Oukka, M., Weiner, H.L. Kuchroo, V.K. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature, 441, 235 238.
-
(2006)
Nature
, vol.441
, pp. 235-238
-
-
Bettelli, E.1
Carrier, Y.2
Gao, W.3
Korn, T.4
Strom, T.B.5
Oukka, M.6
Weiner, H.L.7
Kuchroo, V.K.8
-
14
-
-
33746599842
-
Regulatory T cells in cancer
-
Beyer, M. Schultze, J.L. (2006) Regulatory T cells in cancer. Blood, 108, 804 811.
-
(2006)
Blood
, vol.108
, pp. 804-811
-
-
Beyer, M.1
Schultze, J.L.2
-
15
-
-
33646575622
-
In vivo peripheral expansion of naive CD4+CD25high FoxP3+ regulatory T cells in patients with multiple myeloma
-
Beyer, M., Kochanek, M., Giese, T., Endl, E., Weihrauch, M.R., Knolle, P.A., Classen, S. Schultze, J.L. (2006) In vivo peripheral expansion of naive CD4+CD25high FoxP3+ regulatory T cells in patients with multiple myeloma. Blood, 107, 3940 3949.
-
(2006)
Blood
, vol.107
, pp. 3940-3949
-
-
Beyer, M.1
Kochanek, M.2
Giese, T.3
Endl, E.4
Weihrauch, M.R.5
Knolle, P.A.6
Classen, S.7
Schultze, J.L.8
-
16
-
-
0030860573
-
Distribution of T-cell signalling molecules in human myeloma
-
Bianchi, A., Mariani, S., Beggiato, E., Borrione, P., Peola, S., Boccadoro, M., Pileri, A. Massaia, M. (1997) Distribution of T-cell signalling molecules in human myeloma. British Journal of Haematology, 97, 815 820.
-
(1997)
British Journal of Haematology
, vol.97
, pp. 815-820
-
-
Bianchi, A.1
Mariani, S.2
Beggiato, E.3
Borrione, P.4
Peola, S.5
Boccadoro, M.6
Pileri, A.7
Massaia, M.8
-
17
-
-
0027257608
-
The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell
-
Billadeau, D., Ahmann, G., Greipp, P. Van Ness, B. (1993) The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell. Journal of Experimental Medicine, 178, 1023 1031.
-
(1993)
Journal of Experimental Medicine
, vol.178
, pp. 1023-1031
-
-
Billadeau, D.1
Ahmann, G.2
Greipp, P.3
Van Ness, B.4
-
18
-
-
17944381821
-
Increased conventional chemotherapy does not improve survival in multiple myeloma: Long-term results of two PETHEMA trials including 914 patients
-
Blade, J., San Miguel, J.F., Fontanillas, M., Esteve, J., Maldonado, J., Alcala, A., Brunet, S., Garcia-Conde, J., Besalduch, J., Moro, M.J., Fenandez-Calvo, J., Conde, E., Font, L., Gardella, S., Carnero, M., Carbonell, F., Marti, J.M., Hernandez-Martin, J., Ortega, F., Besses, C., Ribera, J.M., Trujillo, J., Escudero, M.L., Rozman, C., Estape, J. Montserrat, E. (2001) Increased conventional chemotherapy does not improve survival in multiple myeloma: long-term results of two PETHEMA trials including 914 patients. Hematology Journal, 2, 272 278.
-
(2001)
Hematology Journal
, vol.2
, pp. 272-278
-
-
Blade, J.1
San Miguel, J.F.2
Fontanillas, M.3
Esteve, J.4
Maldonado, J.5
Alcala, A.6
Brunet, S.7
Garcia-Conde, J.8
Besalduch, J.9
Moro, M.J.10
Fenandez-Calvo, J.11
Conde, E.12
Font, L.13
Gardella, S.14
Carnero, M.15
Carbonell, F.16
Marti, J.M.17
Hernandez-Martin, J.18
Ortega, F.19
Besses, C.20
Ribera, J.M.21
Trujillo, J.22
Escudero, M.L.23
Rozman, C.24
Estape, J.25
Montserrat, E.26
more..
-
19
-
-
0029906983
-
Peripheral T cell tolerance as a tumor escape mechanism: Deletion of CD4+ T cells specific for a monoclonal immunoglobulin idiotype secreted by a plasmacytoma
-
Bogen, B. (1996) Peripheral T cell tolerance as a tumor escape mechanism: deletion of CD4+ T cells specific for a monoclonal immunoglobulin idiotype secreted by a plasmacytoma. European Journal of Immunology, 26, 2671 2679.
-
(1996)
European Journal of Immunology
, vol.26
, pp. 2671-2679
-
-
Bogen, B.1
-
20
-
-
33745802534
-
Idiotype-specific immunotherapy in multiple myeloma: Suggestions for future directions of research
-
Bogen, B., Ruffini, P.A., Corthay, A., Fredriksen, A.B., Froyland, M., Lundin, K., Rosjo, E., Thompson, K. Massaia, M. (2006) Idiotype-specific immunotherapy in multiple myeloma: suggestions for future directions of research. Haematologica, 91, 941 948.
-
(2006)
Haematologica
, vol.91
, pp. 941-948
-
-
Bogen, B.1
Ruffini, P.A.2
Corthay, A.3
Fredriksen, A.B.4
Froyland, M.5
Lundin, K.6
Rosjo, E.7
Thompson, K.8
Massaia, M.9
-
21
-
-
33744459726
-
Toll-like receptors mediate proliferation and survival of multiple myeloma cells
-
Bohnhorst, J., Rasmussen, T., Moen, S.H., Fløttum, M., Knudsen, L., Børset, M., Espevik, T. Sundan, A. (2006) Toll-like receptors mediate proliferation and survival of multiple myeloma cells. Leukemia, 20, 1138 1144.
-
(2006)
Leukemia
, vol.20
, pp. 1138-1144
-
-
Bohnhorst, J.1
Rasmussen, T.2
Moen, S.H.3
Fløttum, M.4
Knudsen, L.5
Børset, M.6
Espevik, T.7
Sundan, A.8
-
22
-
-
0037114695
-
Altered mRNA expression of Pax5 and Blimp-1 in B cells in multiple myeloma
-
Borson, N.D., Lacy, M.Q. Wettstein, P.J. (2002) Altered mRNA expression of Pax5 and Blimp-1 in B cells in multiple myeloma. Blood, 100, 4629 4639.
-
(2002)
Blood
, vol.100
, pp. 4629-4639
-
-
Borson, N.D.1
Lacy, M.Q.2
Wettstein, P.J.3
-
23
-
-
33645098467
-
Impaired functionality and phenotypic profile of dendritic cells from patients with multiple myeloma
-
Brimnes, M.K., Svane, I.M. Johnsen, H.E. (2006) Impaired functionality and phenotypic profile of dendritic cells from patients with multiple myeloma. Clinical and Experimental Immunology, 144, 76 84.
-
(2006)
Clinical and Experimental Immunology
, vol.144
, pp. 76-84
-
-
Brimnes, M.K.1
Svane, I.M.2
Johnsen, H.E.3
-
24
-
-
18444408375
-
COX-2: A molecular target for colorectal cancer prevention
-
Brown, J.R. DuBois, R.N. (2005) COX-2: a molecular target for colorectal cancer prevention. Journal of Clinical Oncology, 23, 2840 2855.
-
(2005)
Journal of Clinical Oncology
, vol.23
, pp. 2840-2855
-
-
Brown, J.R.1
Dubois, R.N.2
-
25
-
-
0030923576
-
The prognostic significance of T cell receptor beta gene rearrangements and idiotype-reactive T cells in multiple myeloma
-
Brown, R.D., Yuen, E., Nelson, M., Gibson, J. Joshua, D. (1997) The prognostic significance of T cell receptor beta gene rearrangements and idiotype-reactive T cells in multiple myeloma. Leukemia, 11, 1312 1317.
-
(1997)
Leukemia
, vol.11
, pp. 1312-1317
-
-
Brown, R.D.1
Yuen, E.2
Nelson, M.3
Gibson, J.4
Joshua, D.5
-
26
-
-
0032427590
-
The expression of T cell related costimulatory molecules in multiple myeloma
-
Brown, R.D., Pope, B., Yuen, E., Gibson, J. Joshua, D.E. (1998) The expression of T cell related costimulatory molecules in multiple myeloma. Leukemia and Lymphoma, 31, 379 384.
-
(1998)
Leukemia and Lymphoma
, vol.31
, pp. 379-384
-
-
Brown, R.D.1
Pope, B.2
Yuen, E.3
Gibson, J.4
Joshua, D.E.5
-
27
-
-
0035892109
-
Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-beta1 and interleukin-10
-
Brown, R.D., Pope, B., Murray, A., Esdale, W., Sze, D.M., Gibson, J., Ho, P.J., Hart, D. Joshua, D. (2001) Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-beta1 and interleukin-10. Blood, 98, 2992 2998.
-
(2001)
Blood
, vol.98
, pp. 2992-2998
-
-
Brown, R.D.1
Pope, B.2
Murray, A.3
Esdale, W.4
Sze, D.M.5
Gibson, J.6
Ho, P.J.7
Hart, D.8
Joshua, D.9
-
28
-
-
3042691752
-
Either interleukin-12 or interferon-gamma can correct the dendritic cell defect induced by transforming growth factor beta in patients with myeloma
-
Brown, R., Murray, A., Pope, B., Sze, D.m., Gibson, J., Ho, P.J., Hart, D. Joshua, D. (2004) Either interleukin-12 or interferon-gamma can correct the dendritic cell defect induced by transforming growth factor beta in patients with myeloma. British Journal of Haematology, 125, 743 748.
-
(2004)
British Journal of Haematology
, vol.125
, pp. 743-748
-
-
Brown, R.1
Murray, A.2
Pope, B.3
Sze, D.M.4
Gibson, J.5
Ho, P.J.6
Hart, D.7
Joshua, D.8
-
29
-
-
24344471724
-
Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia
-
Bucaneve, G., Micozzi, A., Menichetti, F., Martino, P., Stella Dionisi, M., Martinelli, G., Allione, B., D'Antonio, D., Buelli, M., Nosari, A., Cilloni, D., Zuffa, E., Cantaffa, R., Specchia, G., Amadori, S., Fabbiano, F., Lambertenghi Deliliers, G., Lauria, F., Foà, R. Del Favero, A. (2005) Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. New England Journal of Medicine, 353, 977 987.
-
(2005)
New England Journal of Medicine
, vol.353
, pp. 977-987
-
-
Bucaneve, G.1
Micozzi, A.2
Menichetti, F.3
Martino, P.4
Stella Dionisi, M.5
Martinelli, G.6
Allione, B.7
D'Antonio, D.8
Buelli, M.9
Nosari, A.10
Cilloni, D.11
Zuffa, E.12
Cantaffa, R.13
Specchia, G.14
Amadori, S.15
Fabbiano, F.16
Lambertenghi Deliliers, G.17
Lauria, F.18
Foà, R.19
Del Favero, A.20
more..
-
30
-
-
20144388366
-
Phase 1 clinical trial of anti-CTLA4 human monoclonal antibody CP-675,206 in patients (pts) with advanced solid malignancies
-
No 14S, Abstract 2505.
-
Camacho, L.H., Ribas, A., Glaspy, J.A., Lopez-Berestein, G., Reuben, J.M., Parker, C., Seja, E., Comin-Anduix, B., Bulanhagui, C. Gomez-Navarro, J. (2004) Phase 1 clinical trial of anti-CTLA4 human monoclonal antibody CP-675,206 in patients (pts) with advanced solid malignancies. Journal of Clinical Oncology, 22, No 14S, Abstract 2505.
-
(2004)
Journal of Clinical Oncology
, vol.22
-
-
Camacho, L.H.1
Ribas, A.2
Glaspy, J.A.3
Lopez-Berestein, G.4
Reuben, J.M.5
Parker, C.6
Seja, E.7
Comin-Anduix, B.8
Bulanhagui, C.9
Gomez-Navarro, J.10
-
31
-
-
0035399605
-
Suppression of IL-2-induced T cell proliferation and phosphorylation of STAT3 and STAT5 by tumor-derived TGF beta is reversed by IL-15
-
Campbell, J.D., Cook, G., Robertson, S.E., Fraser, A., Gracie, J.A. Franklin, I.M. (2001) Suppression of IL-2-induced T cell proliferation and phosphorylation of STAT3 and STAT5 by tumor-derived TGF beta is reversed by IL-15. Journal of Immunology, 167, 553 561.
-
(2001)
Journal of Immunology
, vol.167
, pp. 553-561
-
-
Campbell, J.D.1
Cook, G.2
Robertson, S.E.3
Fraser, A.4
Gracie, J.A.5
Franklin, I.M.6
-
32
-
-
19944428928
-
HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells
-
Carbone, E., Neri, P., Mesuraca, M., Fulciniti, M.T., Otsuki, T., Pende, D., Groh, V., Spies, T., Pollio, G., Cosman, D., Catalano, L., Tassone, P., Rotoli, B. Venuta, S. (2005) HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells. Blood, 105, 251 258.
-
(2005)
Blood
, vol.105
, pp. 251-258
-
-
Carbone, E.1
Neri, P.2
Mesuraca, M.3
Fulciniti, M.T.4
Otsuki, T.5
Pende, D.6
Groh, V.7
Spies, T.8
Pollio, G.9
Cosman, D.10
Catalano, L.11
Tassone, P.12
Rotoli, B.13
Venuta, S.14
-
33
-
-
22544457164
-
Human tumor antigen MUC1 is chemotactic for immature dendritic cells and elicits maturation but does not promote Th1 type immunity
-
Carlos, C.A., Dong, H.F., Howard, O.M., Oppenheim, J.J., Hanisch, F.G. Finn, O.J. (2005) Human tumor antigen MUC1 is chemotactic for immature dendritic cells and elicits maturation but does not promote Th1 type immunity. Journal of Immunology, 175, 1628 1635.
-
(2005)
Journal of Immunology
, vol.175
, pp. 1628-1635
-
-
Carlos, C.A.1
Dong, H.F.2
Howard, O.M.3
Oppenheim, J.J.4
Hanisch, F.G.5
Finn, O.J.6
-
34
-
-
33745961875
-
Enhancement of ligand dependent activation of human natural killer T cells by lenalidomide: Therapeutic implications
-
Chang, D.H., Liu, N., Klimek, V., Hassoun, H., Mazumder, A., Nimer, S.D., Jagannath, S. Dhodapkar, M.V. (2006) Enhancement of ligand dependent activation of human natural killer T cells by lenalidomide: therapeutic implications. Blood, 108, 618 621.
-
(2006)
Blood
, vol.108
, pp. 618-621
-
-
Chang, D.H.1
Liu, N.2
Klimek, V.3
Hassoun, H.4
Mazumder, A.5
Nimer, S.D.6
Jagannath, S.7
Dhodapkar, M.V.8
-
35
-
-
0028230488
-
Randomised trial of intravenous immunoglobulin as prophylaxis against infection in plateau-phase multiple myeloma. the UK Group for Immunoglobulin Replacement Therapy in Multiple Myeloma
-
Chapel, H.M., Lee, M., Hargreaves, R., Pamphilon, D.H. Prentice, A.G. (1994) Randomised trial of intravenous immunoglobulin as prophylaxis against infection in plateau-phase multiple myeloma. The UK Group for Immunoglobulin Replacement Therapy in Multiple Myeloma. Lancet, 343, 1059 1063.
-
(1994)
Lancet
, vol.343
, pp. 1059-1063
-
-
Chapel, H.M.1
Lee, M.2
Hargreaves, R.3
Pamphilon, D.H.4
Prentice, A.G.5
-
36
-
-
20144383847
-
Enrichment of functional CD8 memory T cells specific for MUC1 in bone marrow of patients with multiple myeloma
-
Choi, C., Witzens, M., Bucur, M., Feuerer, M., Sommerfeldt, N., Trojan, A., Ho, A., Schirrmacher, V., Goldschmidt, H. Beckhove, P. (2005) Enrichment of functional CD8 memory T cells specific for MUC1 in bone marrow of patients with multiple myeloma. Blood, 105, 2132 2134.
-
(2005)
Blood
, vol.105
, pp. 2132-2134
-
-
Choi, C.1
Witzens, M.2
Bucur, M.3
Feuerer, M.4
Sommerfeldt, N.5
Trojan, A.6
Ho, A.7
Schirrmacher, V.8
Goldschmidt, H.9
Beckhove, P.10
-
37
-
-
33646869754
-
Functional regulatory T cells are collected in stem cell autografts by mobilization with high-dose cyclophosphamide and granulocyte colony-stimulating factor
-
Condomines, M., Quittet, P., Zhao-Yang L., Nadal, L., Latry, P., Lopez, E., Baudard, M., Requirand, G., Duperray, C., Schved, J.F., Rossi, J.F., Tarte, K. Klein, B. (2006) Functional regulatory T cells are collected in stem cell autografts by mobilization with high-dose cyclophosphamide and granulocyte colony-stimulating factor. Journal of Immunology, 176, 6631 6639.
-
(2006)
Journal of Immunology
, vol.176
, pp. 6631-6639
-
-
Condomines, M.1
Quittet, P.2
Zhao-Yang, L.3
Nadal, L.4
Latry, P.5
Lopez, E.6
Baudard, M.7
Requirand, G.8
Duperray, C.9
Schved, J.F.10
Rossi, J.F.11
Tarte, K.12
Klein, B.13
-
38
-
-
0032873880
-
Immune regulation in multiple myeloma: The host-tumour conflict
-
Cook, G. Campbell, J.D. (1999) Immune regulation in multiple myeloma: the host-tumour conflict. Blood Reviews, 13, 151 162
-
(1999)
Blood Reviews
, vol.13
, pp. 151-162
-
-
Cook, G.1
Campbell, J.D.2
-
39
-
-
0033454740
-
Transforming growth factor beta from multiple myeloma cells inhibits proliferation and IL-2 responsiveness in T lymphocytes
-
Cook, G., Campbell, J.D., Carr, C.E., Boyd, K.S. Franklin, I.M. (1999) Transforming growth factor beta from multiple myeloma cells inhibits proliferation and IL-2 responsiveness in T lymphocytes. Journal of Leukocyte Biology, 66, 981 988.
-
(1999)
Journal of Leukocyte Biology
, vol.66
, pp. 981-988
-
-
Cook, G.1
Campbell, J.D.2
Carr, C.E.3
Boyd, K.S.4
Franklin, I.M.5
-
40
-
-
0033168605
-
Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha
-
Corral, L.G., Haslett, P.A., Muller, G.W., Chen, R., Wong, L.M., Ocampo, C.J., Patterson, R.T., Stirling, D.I. Kaplan, G. (1999) Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha. Journal of Immunology, 163, 380 386.
-
(1999)
Journal of Immunology
, vol.163
, pp. 380-386
-
-
Corral, L.G.1
Haslett, P.A.2
Muller, G.W.3
Chen, R.4
Wong, L.M.5
Ocampo, C.J.6
Patterson, R.T.7
Stirling, D.I.8
Kaplan, G.9
-
41
-
-
0742324478
-
Long-term follow-up of idiotype vaccination in human myeloma as a maintenance therapy after high-dose chemotherapy
-
Coscia, M., Mariani, S., Battaglio, S., DiBello, C., Fiore, F., Foglietta, M., Pileri, A., Boccadoro, M. Massaia, M. (2004) Long-term follow-up of idiotype vaccination in human myeloma as a maintenance therapy after high-dose chemotherapy. Leukemia, 18, 139 145.
-
(2004)
Leukemia
, vol.18
, pp. 139-145
-
-
Coscia, M.1
Mariani, S.2
Battaglio, S.3
Dibello, C.4
Fiore, F.5
Foglietta, M.6
Pileri, A.7
Boccadoro, M.8
Massaia, M.9
-
42
-
-
21144446701
-
Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: An analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT
-
Apperley JF for the Chronic Leukaemia Working Party of the EBMT (
-
Crawley, C., Lalancette, M., Szydlo, R., Gilleece Peggs, K., Mackinnon, S., Juliusson, G., Ahlberg, L., Nagler, A., Shimoni, A., Sureda, A., Boiron, J.M., Einsele, H., Chopra, R., Carella, A., Cavenagh, J., Gratwohl, A., Garban, F., Zander, A., Björkstrand, B., Niederwieser, D. Gahrton, G. Apperley JF for the Chronic Leukaemia Working Party of the EBMT (2005) Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT. Blood, 105, 4532 4539.
-
(2005)
Blood
, vol.105
, pp. 4532-4539
-
-
Crawley, C.1
Lalancette, M.2
Szydlo, R.3
Gilleece Peggs, K.4
MacKinnon, S.5
Juliusson, G.6
Ahlberg, L.7
Nagler, A.8
Shimoni, A.9
Sureda, A.10
Boiron, J.M.11
Einsele, H.12
Chopra, R.13
Carella, A.14
Cavenagh, J.15
Gratwohl, A.16
Garban, F.17
Zander, A.18
Björkstrand, B.19
Niederwieser, D.20
Gahrton, G.21
more..
-
43
-
-
34147144964
-
Reduced-intensity conditioning for myeloma: Lower nonrelapse mortality but higher relapse rates compared with myeloablative conditioning
-
Crawley, C., Iacobelli, S., Bjorkstrand, B., Apperley, J.F., Niederwieser, D. Gahrton, G. (2007) Reduced-intensity conditioning for myeloma: lower nonrelapse mortality but higher relapse rates compared with myeloablative conditioning. Blood, 109, 3588 3594.
-
(2007)
Blood
, vol.109
, pp. 3588-3594
-
-
Crawley, C.1
Iacobelli, S.2
Bjorkstrand, B.3
Apperley, J.F.4
Niederwieser, D.5
Gahrton, G.6
-
44
-
-
0032731377
-
Generation of anti-idiotype immune responses following vaccination with idiotype-protein pulsed dendritic cells in myeloma
-
Cull, G., Durrant, L., Stainer, C., Haynes, A. Russell, N. (1999) Generation of anti-idiotype immune responses following vaccination with idiotype-protein pulsed dendritic cells in myeloma. British Journal of Haematology, 107, 648 655.
-
(1999)
British Journal of Haematology
, vol.107
, pp. 648-655
-
-
Cull, G.1
Durrant, L.2
Stainer, C.3
Haynes, A.4
Russell, N.5
-
45
-
-
24344445873
-
Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas
-
Cullen, M., Steven, N., Billingham, L., Gaunt, C., Hastings, M., Simmonds, P., Stuart, N., Rea, D., Bower, M., Fernando, I., Huddart, R., Gollins, S. Stanley, A. (2005) Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas. New England Journal of Medicine, 353, 988 998.
-
(2005)
New England Journal of Medicine
, vol.353
, pp. 988-998
-
-
Cullen, M.1
Steven, N.2
Billingham, L.3
Gaunt, C.4
Hastings, M.5
Simmonds, P.6
Stuart, N.7
Rea, D.8
Bower, M.9
Fernando, I.10
Huddart, R.11
Gollins, S.12
Stanley, A.13
-
46
-
-
0035412366
-
Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma
-
Davies, F.E., Raje, N., Hideshima, T., Lentzsch, S., Young, G., Tai, Y.T., Lin, B., Podar, K., Gupta, D., Chauhan, D., Treon, S.P., Richardson, P.G., Schlossman, R.L., Morgan, G.J., Muller, G.W., Stirling, D.I. Anderson, K.C. (2001) Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma. Blood, 98, 210 216.
-
(2001)
Blood
, vol.98
, pp. 210-216
-
-
Davies, F.E.1
Raje, N.2
Hideshima, T.3
Lentzsch, S.4
Young, G.5
Tai, Y.T.6
Lin, B.7
Podar, K.8
Gupta, D.9
Chauhan, D.10
Treon, S.P.11
Richardson, P.G.12
Schlossman, R.L.13
Morgan, G.J.14
Muller, G.W.15
Stirling, D.I.16
Anderson, K.C.17
-
47
-
-
0038543513
-
A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma
-
Dhodapkar, M.V., Geller, M.D., Chang, D.H., Shimizu, K., Fujii, S.I., Dhodapkar, K.M. Krasovsky, J. (2003a) A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma. Journal of Experimental Medicine, 198, 1667 1676.
-
(2003)
Journal of Experimental Medicine
, vol.198
, pp. 1667-1676
-
-
Dhodapkar, M.V.1
Geller, M.D.2
Chang, D.H.3
Shimizu, K.4
Fujii, S.I.5
Dhodapkar, K.M.6
Krasovsky, J.7
-
48
-
-
0345599884
-
Vigorous premalignancy-specific effector T cell response in the bone marrow of patients with monoclonal gammopathy
-
Dhodapkar, M.V., Krasovsky, J., Osman, K. Geller, M.D. (2003b) Vigorous premalignancy-specific effector T cell response in the bone marrow of patients with monoclonal gammopathy. Journal of Experimental Medicine, 198, 1753 1757.
-
(2003)
Journal of Experimental Medicine
, vol.198
, pp. 1753-1757
-
-
Dhodapkar, M.V.1
Krasovsky, J.2
Osman, K.3
Geller, M.D.4
-
49
-
-
0036889996
-
The two faces of IL-6 on Th1/Th2 differentiation
-
Diehl, S. Rincon, M. (2002) The two faces of IL-6 on Th1/Th2 differentiation. Molecular Immunology, 39, 531 536.
-
(2002)
Molecular Immunology
, vol.39
, pp. 531-536
-
-
Diehl, S.1
Rincon, M.2
-
50
-
-
34547681086
-
Lenalidomide with Dexamethasone is more effective than dexamethasone alone in patients with refractory/relapse MM and independent of number of previous treatments
-
Abstract 0494.
-
Dimopoulos, A., Anagnostopoulos, A., Prince, M., Harrousseau, J.L., Dmoszynka, A., Hellmann, A., Masliak, Z., Lazzarino, M., Facon, T., Foa, R., Zeldis, J., Yu, Z., Olesnyckyj, M., Faleck, H. Knight, R. (2006) Lenalidomide with Dexamethasone is more effective than dexamethasone alone in patients with refractory/relapse MM and independent of number of previous treatments. Haematologica, 91 (Suppl. 1 Abstract 0494.
-
(2006)
Haematologica
, vol.91
, Issue.1
-
-
Dimopoulos, A.1
Anagnostopoulos, A.2
Prince, M.3
Harrousseau, J.L.4
Dmoszynka, A.5
Hellmann, A.6
Masliak, Z.7
Lazzarino, M.8
Facon, T.9
Foa, R.10
Zeldis, J.11
Yu, Z.12
Olesnyckyj, M.13
Faleck, H.14
Knight, R.15
-
51
-
-
0037093854
-
Protective antitumor immunity induced by a costimulatory thalidomide analog in conjunction with whole tumor cell vaccination is mediated by increased Th1-type immunity
-
Dredge, K., Marriott, J.B., Todryk, S.M., Muller, G.W., Chen, R., Stirling, D.I. Dalgleish, A.G. (2002) Protective antitumor immunity induced by a costimulatory thalidomide analog in conjunction with whole tumor cell vaccination is mediated by increased Th1-type immunity. Journal of Immunology, 168, 4914 4919.
-
(2002)
Journal of Immunology
, vol.168
, pp. 4914-4919
-
-
Dredge, K.1
Marriott, J.B.2
Todryk, S.M.3
Muller, G.W.4
Chen, R.5
Stirling, D.I.6
Dalgleish, A.G.7
-
52
-
-
0024505031
-
Phenotypic analysis of human myeloma cell lines
-
Duperray, C., Klein, B., Durie, B.G.M., Zhang, X., Jourdan, M., Poncelet, P., Favier, F., Vincent, C., Brochier, J., Lenoir, G. Bataille, R. (1989) Phenotypic analysis of human myeloma cell lines. Blood, 73, 566 572.
-
(1989)
Blood
, vol.73
, pp. 566-572
-
-
Duperray, C.1
Klein, B.2
Durie, B.G.M.3
Zhang, X.4
Jourdan, M.5
Poncelet, P.6
Favier, F.7
Vincent, C.8
Brochier, J.9
Lenoir, G.10
Bataille, R.11
-
53
-
-
0345365618
-
HLA class II as potential target antigen on malignant B cells for therapy with bispecific antibodies in combination with granulocyte colony-stimulating factor
-
Elsasser, D., Valerius, T., Repp, R., Weiner, G.J., Deo, Y., Kalden, J.R., de Winkel, J.G.J., Stevenson, G.T., Glennie, M.J. Gramatzki, M. (1996) HLA class II as potential target antigen on malignant B cells for therapy with bispecific antibodies in combination with granulocyte colony-stimulating factor. Blood, 87, 3803 3812.
-
(1996)
Blood
, vol.87
, pp. 3803-3812
-
-
Elsasser, D.1
Valerius, T.2
Repp, R.3
Weiner, G.J.4
Deo, Y.5
Kalden, J.R.6
De Winkel, J.G.J.7
Stevenson, G.T.8
Glennie, M.J.9
Gramatzki, M.10
-
54
-
-
33646477295
-
Impaired activating receptor expression pattern in natural killer cells from patients with multiple myeloma
-
Fauriat, C., Mallet, F., Olive, D. Costello, R.T. (2006) Impaired activating receptor expression pattern in natural killer cells from patients with multiple myeloma. Leukemia, 20, 732 733.
-
(2006)
Leukemia
, vol.20
, pp. 732-733
-
-
Fauriat, C.1
Mallet, F.2
Olive, D.3
Costello, R.T.4
-
55
-
-
0034881738
-
Deregulated cytokine network and defective Th1 immune response in multiple myeloma
-
Frassanito, M.A., Cusmai, A. Dammacco, F. (2001) Deregulated cytokine network and defective Th1 immune response in multiple myeloma. Clinical and Experimental Immunology, 125, 190 197.
-
(2001)
Clinical and Experimental Immunology
, vol.125
, pp. 190-197
-
-
Frassanito, M.A.1
Cusmai, A.2
Dammacco, F.3
-
56
-
-
0036434914
-
Anti-myeloma activity of natural killer lymphocytes
-
Frohn, C., Hoppner, M., Schlenke, P., Kirchner, H., Koritke, P. Luhm, J. (2002) Anti-myeloma activity of natural killer lymphocytes. British Journal of Haematology, 119, 660 664.
-
(2002)
British Journal of Haematology
, vol.119
, pp. 660-664
-
-
Frohn, C.1
Hoppner, M.2
Schlenke, P.3
Kirchner, H.4
Koritke, P.5
Luhm, J.6
-
57
-
-
0032400862
-
Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo
-
Gabrilovich, D., Ishida, T., Oyama, T., Ran, S., Kravtsov, V., Nadaf, S. Carbone, D.P. (1998) Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood, 92, 4150 4166.
-
(1998)
Blood
, vol.92
, pp. 4150-4166
-
-
Gabrilovich, D.1
Ishida, T.2
Oyama, T.3
Ran, S.4
Kravtsov, V.5
Nadaf, S.6
Carbone, D.P.7
-
58
-
-
0032862958
-
Syngeneic transplantation in multiple myeloma - A case-matched comparison with autologous and allogeneic transplantation. European Group for Blood and Marrow Transplantation
-
Gahrton, G., Svensson, H., Bjorkstand, B., Apperley, J., Carlson, K., Cavo, M., Ferrant, A., Fouillard, L., Gratecos, N., Gratwohl, A., Guilhot, F., Lambertenghi Deliliers, G., Ljungman, P., Masszi, T., Milligan, D.W., Powles, R.L., Reiffers, J., Samson, J.D., Stoppa, A.M., Vernant, J.P., Volin, L. Wallvik, J. (1999) Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation. European Group for Blood and Marrow Transplantation. Bone Marrow Transplantion, 24, 741 745.
-
(1999)
Bone Marrow Transplantion
, vol.24
, pp. 741-745
-
-
Gahrton, G.1
Svensson, H.2
Bjorkstand, B.3
Apperley, J.4
Carlson, K.5
Cavo, M.6
Ferrant, A.7
Fouillard, L.8
Gratecos, N.9
Gratwohl, A.10
Guilhot, F.11
Lambertenghi Deliliers, G.12
Ljungman, P.13
Masszi, T.14
Milligan, D.W.15
Powles, R.L.16
Reiffers, J.17
Samson, J.D.18
Stoppa, A.M.19
Vernant, J.P.20
Volin, L.21
Wallvik, J.22
more..
-
59
-
-
16144363002
-
Breast cancer-associated antigen, DF3/MUC1, induces apoptosis of activated human T cells
-
Gimmi, C.D., Morrison, B.W., Mainprice, B.A., Gribben, J.G., Boussiotis, V.A., Freeman, G.J., Park, S.Y.L., Watanabe, M., Gong, J., Hayes, D.F., Kufe, D.W. Nadler, L.M. (1996) Breast cancer-associated antigen, DF3/MUC1, induces apoptosis of activated human T cells. Nature Medicine, 2, 1367 1370.
-
(1996)
Nature Medicine
, vol.2
, pp. 1367-1370
-
-
Gimmi, C.D.1
Morrison, B.W.2
Mainprice, B.A.3
Gribben, J.G.4
Boussiotis, V.A.5
Freeman, G.J.6
Park, S.Y.L.7
Watanabe, M.8
Gong, J.9
Hayes, D.F.10
Kufe, D.W.11
Nadler, L.M.12
-
60
-
-
23844514335
-
MICA expressed by multiple myeloma and monoclonal gammopathy of undetermined significance plasma cells Costimulates pamidronate-activated gammadelta lymphocytes
-
Girlanda, S., Fortis, C., Belloni, D., Ferrero, E., Ticozzi, P., Sciorati, C., Tresoldi, M., Vicari, A., Spies, T., Groh, V., Caligaris-Cappio, F. Ferrarini, M. (2005) MICA expressed by multiple myeloma and monoclonal gammopathy of undetermined significance plasma cells Costimulates pamidronate-activated gammadelta lymphocytes. Cancer Research, 65, 7502 7508.
-
(2005)
Cancer Research
, vol.65
, pp. 7502-7508
-
-
Girlanda, S.1
Fortis, C.2
Belloni, D.3
Ferrero, E.4
Ticozzi, P.5
Sciorati, C.6
Tresoldi, M.7
Vicari, A.8
Spies, T.9
Groh, V.10
Caligaris-Cappio, F.11
Ferrarini, M.12
-
61
-
-
28844462429
-
CD8 T-cells specific for cancer-testis antigens are found in many patients with multiple myeloma and their frequency correlates with disease burden
-
Goodyear, O., Piper, K., Khan, N., Starczynski, J., Mahendra, P., Pratt, G. Moss, P. (2005) CD8 T-cells specific for cancer-testis antigens are found in many patients with multiple myeloma and their frequency correlates with disease burden. Blood, 106, 4217 4224.
-
(2005)
Blood
, vol.106
, pp. 4217-4224
-
-
Goodyear, O.1
Piper, K.2
Khan, N.3
Starczynski, J.4
Mahendra, P.5
Pratt, G.6
Moss, P.7
-
62
-
-
0036372440
-
Transforming growth factor-beta in T-cell biology
-
Gorelik, L. Flavell, R.A. (2002) Transforming growth factor-beta in T-cell biology. Nature Reviews Immunology, 2, 46 53.
-
(2002)
Nature Reviews Immunology
, vol.2
, pp. 46-53
-
-
Gorelik, L.1
Flavell, R.A.2
-
63
-
-
33947359949
-
Long-term idiotype vaccination combined with interleukin-12 (IL-12), or IL-12 and granulocyte macrophage colony-stimulating factor, in early-stage multiple myeloma patients
-
Hansson, L., Abdalla, A.O., Moshfegh, A., Choudhury, A., Rabbani, H., Nilsson, B., Osterborg, A. Mellstedt, H. (2007) Long-term idiotype vaccination combined with interleukin-12 (IL-12), or IL-12 and granulocyte macrophage colony-stimulating factor, in early-stage multiple myeloma patients. Clinical Cancer Research, 13, 1503 1510.
-
(2007)
Clinical Cancer Research
, vol.13
, pp. 1503-1510
-
-
Hansson, L.1
Abdalla, A.O.2
Moshfegh, A.3
Choudhury, A.4
Rabbani, H.5
Nilsson, B.6
Osterborg, A.7
Mellstedt, H.8
-
64
-
-
24944449622
-
Immunotherapy in multiple myeloma-possibility or probability?
-
Harrison, S.J. Cook, G. (2005) Immunotherapy in multiple myeloma-possibility or probability? British Journal of Haematology, 130, 344 362.
-
(2005)
British Journal of Haematology
, vol.130
, pp. 344-362
-
-
Harrison, S.J.1
Cook, G.2
-
65
-
-
0030746472
-
The metabolic and immunologic effects of short-term thalidomide treatment of patients infected with the human immunodeficiency virus
-
Haslett, P., Hempstead, M., Seidman, C., Diakun, J., Vasquez, D., Freedman, V.H. Kaplan, G. (1997) The metabolic and immunologic effects of short-term thalidomide treatment of patients infected with the human immunodeficiency virus. AIDS Research and Human Retroviruses, 13, 1047 1054.
-
(1997)
AIDS Research and Human Retroviruses
, vol.13
, pp. 1047-1054
-
-
Haslett, P.1
Hempstead, M.2
Seidman, C.3
Diakun, J.4
Vasquez, D.5
Freedman, V.H.6
Kaplan, G.7
-
66
-
-
0032100486
-
Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production and cytotoxic responses in the CD8+ subset
-
Haslett, P.A., Corral, L.G., Albert, M. Kaplan, G. (1998) Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production and cytotoxic responses in the CD8+ subset. Journal of Experimental Medicine, 187, 1885 1892.
-
(1998)
Journal of Experimental Medicine
, vol.187
, pp. 1885-1892
-
-
Haslett, P.A.1
Corral, L.G.2
Albert, M.3
Kaplan, G.4
-
67
-
-
0037444106
-
Thalidomide and a thalidomide analogue drug costimulate via specific CD8+ T cells in vitro
-
Haslett, P.A., Hanekom, W.A., Muller, G. Kaplan, G. (2003) Thalidomide and a thalidomide analogue drug costimulate via specific CD8+ T cells in vitro. Journal of Infectious disease, 187, 946 955
-
(2003)
Journal of Infectious Disease
, vol.187
, pp. 946-955
-
-
Haslett, P.A.1
Hanekom, W.A.2
Muller, G.3
Kaplan, G.4
-
68
-
-
19944430437
-
Molecular mechanisms whereby immunomodulatory drugs activate natural killer cells: Clinical application
-
Hayashi, T., Hideshima, T., Akiyama, M., Podar, K., Yasui, H., Raje, N., Kumar, S., Chauhan, D., Treon, S.P., Richardson, P. Anderson, K.C. (2005) Molecular mechanisms whereby immunomodulatory drugs activate natural killer cells: clinical application. British Journal of Haematology, 128, 192 203.
-
(2005)
British Journal of Haematology
, vol.128
, pp. 192-203
-
-
Hayashi, T.1
Hideshima, T.2
Akiyama, M.3
Podar, K.4
Yasui, H.5
Raje, N.6
Kumar, S.7
Chauhan, D.8
Treon, S.P.9
Richardson, P.10
Anderson, K.C.11
-
69
-
-
9444287003
-
Novel immunosuppressive properties of interleukin-6 in dendritic cells: Inhibition of NF-kappaB binding activity and CCR7 expression
-
Hegde, S., Pahne, J. Smola-Hess, S. (2004) Novel immunosuppressive properties of interleukin-6 in dendritic cells: inhibition of NF-kappaB binding activity and CCR7 expression. FASEB J., 18, 1439 1441.
-
(2004)
FASEB J.
, vol.18
, pp. 1439-1441
-
-
Hegde, S.1
Pahne, J.2
Smola-Hess, S.3
-
70
-
-
0036433103
-
Interleukin-6 promotes the production of interleukin-4 and interleukin-5 by interleukin-2-dependent and -independent mechanisms in freshly isolated human T cells
-
Heijink, I.H., Vellenga, E., Borger, P., Postma, D.S., de Monchy, J.G. Kauffman, H.F. (2002) Interleukin-6 promotes the production of interleukin-4 and interleukin-5 by interleukin-2-dependent and -independent mechanisms in freshly isolated human T cells. Immunology, 107, 316 324.
-
(2002)
Immunology
, vol.107
, pp. 316-324
-
-
Heijink, I.H.1
Vellenga, E.2
Borger, P.3
Postma, D.S.4
De Monchy, J.G.5
Kauffman, H.F.6
-
71
-
-
0344341626
-
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
-
Hodi, F.S., Mihm, M.C., Soiffer, R.J., Haluska, F.G., Butler, M., Seiden, M.V., Davis, T., Henry-Spires, R., MacRae, S., Willman, A., Padera, R., Jaklitsch, M.T., Shankar, S., Chen, T.C., Korman, A., Allison, J.P. Dranoff, G. (2003) Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients. Proceedings of the National academy of scientists U S A, 100, 4712 4717.
-
(2003)
Proceedings of the National Academy of Scientists U S a
, vol.100
, pp. 4712-4717
-
-
Hodi, F.S.1
Mihm, M.C.2
Soiffer, R.J.3
Haluska, F.G.4
Butler, M.5
Seiden, M.V.6
Davis, T.7
Henry-Spires, R.8
MacRae, S.9
Willman, A.10
Padera, R.11
Jaklitsch, M.T.12
Shankar, S.13
Chen, T.C.14
Korman, A.15
Allison, J.P.16
Dranoff, G.17
-
72
-
-
33746361186
-
Active immunotherapy of multiple myeloma
-
Houet, L. Veelken, H. (2006) Active immunotherapy of multiple myeloma. European Journal of Cancer, 42, 1653 1660.
-
(2006)
European Journal of Cancer
, vol.42
, pp. 1653-1660
-
-
Houet, L.1
Veelken, H.2
-
73
-
-
25844480853
-
Tumor counterattack: Fact or fiction?
-
Igney, F.H. Krammer, P.H. (2005) Tumor counterattack: fact or fiction? Cancer Immunology, Immunotherapy, 54, 1127 1136.
-
(2005)
Cancer Immunology, Immunotherapy
, vol.54
, pp. 1127-1136
-
-
Igney, F.H.1
Krammer, P.H.2
-
74
-
-
0023032745
-
Immunosuppression and infection in multiple myeloma
-
Jacobson, D.R. Zolla-Pazner, S. (1986) Immunosuppression and infection in multiple myeloma. Seminars in Oncology, 13, 282 290.
-
(1986)
Seminars in Oncology
, vol.13
, pp. 282-290
-
-
Jacobson, D.R.1
Zolla-Pazner, S.2
-
75
-
-
34247507209
-
Blockade of natural killer cell-mediated lysis by NCAM140 expressed on tumor cells
-
Jarahian, M., Watzl, C., Issa, Y., Altevogt, P. Momburg, F. (2007) Blockade of natural killer cell-mediated lysis by NCAM140 expressed on tumor cells. International Journal of Cancer, 120, 2625 2634.
-
(2007)
International Journal of Cancer
, vol.120
, pp. 2625-2634
-
-
Jarahian, M.1
Watzl, C.2
Issa, Y.3
Altevogt, P.4
Momburg, F.5
-
76
-
-
33744465220
-
Pathogen-associated molecular patterns are growth and survival factors for human myeloma cells through Toll-like receptors
-
Jego, G., Bataille, R., Geffroy-Luseau, A., Descamps, G. Pellat-Deceunynck, C. (2006) Pathogen-associated molecular patterns are growth and survival factors for human myeloma cells through Toll-like receptors. Leukemia, 20, 1130 1137.
-
(2006)
Leukemia
, vol.20
, pp. 1130-1137
-
-
Jego, G.1
Bataille, R.2
Geffroy-Luseau, A.3
Descamps, G.4
Pellat-Deceunynck, C.5
-
77
-
-
22044451852
-
The cancer-testis antigens CT7 (MAGE-C1) and MAGE-A3/6 are commonly expressed in multiple myeloma and correlate with plasma-cell proliferation
-
Jungbluth, A.A., Ely, S., DiLiberto, M., Niesvizky, R., Williamson, B., Frosina, D., Chen, Y.T., Bhardwaj, N., Chen-Kiang, S., Old, L.J. Cho, H.J. (2005) The cancer-testis antigens CT7 (MAGE-C1) and MAGE-A3/6 are commonly expressed in multiple myeloma and correlate with plasma-cell proliferation. Blood, 106, 167 174.
-
(2005)
Blood
, vol.106
, pp. 167-174
-
-
Jungbluth, A.A.1
Ely, S.2
Diliberto, M.3
Niesvizky, R.4
Williamson, B.5
Frosina, D.6
Chen, Y.T.7
Bhardwaj, N.8
Chen-Kiang, S.9
Old, L.J.10
Cho, H.J.11
-
78
-
-
0030991936
-
Circulating blood B cells in multiple myeloma: Analysis and relationship to circulating clonal cells and clinical parameters in a cohort of patients entered on the Eastern Cooperative Oncology Group phase III E9486 clinical trial
-
Kay, N.E., Leong, T., Kyle, R.A., Greipp, P., Billadeau, D., Van Ness, B., Bone, N. Oken, M.M. (1997) Circulating blood B cells in multiple myeloma: analysis and relationship to circulating clonal cells and clinical parameters in a cohort of patients entered on the Eastern Cooperative Oncology Group phase III E9486 clinical trial. Blood, 90, 340 345.
-
(1997)
Blood
, vol.90
, pp. 340-345
-
-
Kay, N.E.1
Leong, T.2
Kyle, R.A.3
Greipp, P.4
Billadeau, D.5
Van Ness, B.6
Bone, N.7
Oken, M.M.8
-
79
-
-
0031864211
-
T-helper phenotypes in the blood of myeloma patients on ECOG phase III trials E9486/E3A93
-
Kay, N.E., Leong, T., Bone, N., Kyle, R.A., Greipp, P.R., Van Ness, B. Oken, M.M. (1998) T-helper phenotypes in the blood of myeloma patients on ECOG phase III trials E9486/E3A93. British Journal of Haematology, 100, 459 463.
-
(1998)
British Journal of Haematology
, vol.100
, pp. 459-463
-
-
Kay, N.E.1
Leong, T.2
Bone, N.3
Kyle, R.A.4
Greipp, P.R.5
Van Ness, B.6
Oken, M.M.7
-
80
-
-
0035412356
-
Blood levels of immune cells predict survival in myeloma patients: Results of an Eastern Cooperative Oncology Group phase 3 trial for newly diagnosed multiple myeloma patients
-
Kay, N.E., Leong, T.L., Bone, N., Vesole, D.H., Greipp, P.R., Van Ness, B., Oken, M.M. Kyle, R.A. (2001) Blood levels of immune cells predict survival in myeloma patients: results of an Eastern Cooperative Oncology Group phase 3 trial for newly diagnosed multiple myeloma patients. Blood, 98, 23 28.
-
(2001)
Blood
, vol.98
, pp. 23-28
-
-
Kay, N.E.1
Leong, T.L.2
Bone, N.3
Vesole, D.H.4
Greipp, P.R.5
Van Ness, B.6
Oken, M.M.7
Kyle, R.A.8
-
81
-
-
0344731254
-
Interleukin-10 and Gp130 cytokines in human multiple myeloma
-
Klein, B., Lu, Z.Y., Gu, Z.J., Costes, V., Jourdan, M. Rossi, J.F. (1999) Interleukin-10 and Gp130 cytokines in human multiple myeloma. Leukemia and Lymphoma, 34, 63 70.
-
(1999)
Leukemia and Lymphoma
, vol.34
, pp. 63-70
-
-
Klein, B.1
Lu, Z.Y.2
Gu, Z.J.3
Costes, V.4
Jourdan, M.5
Rossi, J.F.6
-
82
-
-
18544390035
-
Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis
-
Koh, K.R., Janz, M., Mapara, M.Y., Lemke, B., Stirling, D., Dorken, B., Zenke, M. Lentzsch, S. (2005) Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis. Blood, 105, 3833 3840.
-
(2005)
Blood
, vol.105
, pp. 3833-3840
-
-
Koh, K.R.1
Janz, M.2
Mapara, M.Y.3
Lemke, B.4
Stirling, D.5
Dorken, B.6
Zenke, M.7
Lentzsch, S.8
-
83
-
-
0034660687
-
Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma
-
Kunzmann, B., Bauer, E., Feurle, J., Weissinger, F., Tony, H.P. Wilhelm, M. (2000) Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. Blood, 96, 384 392.
-
(2000)
Blood
, vol.96
, pp. 384-392
-
-
Kunzmann, B.1
Bauer, E.2
Feurle, J.3
Weissinger, F.4
Tony, H.P.5
Wilhelm, M.6
-
84
-
-
33747480248
-
Monoclonal gammopathy of undetermined significance
-
Kyle, R.A. Rajkumar, S.V. (2006) Monoclonal gammopathy of undetermined significance. British Journal of Haematology, 134, 573 589.
-
(2006)
British Journal of Haematology
, vol.134
, pp. 573-589
-
-
Kyle, R.A.1
Rajkumar, S.V.2
-
85
-
-
33845953091
-
Respiratory tract infections in the pathway to multiple myeloma: A population-based study in Scandinavia
-
Landgren, O., Rapkin, J.S., Mellemkjaer, L., Gridley, G., Goldin, L.R. Engels, E.A. (2006) Respiratory tract infections in the pathway to multiple myeloma: a population-based study in Scandinavia. Haematologica, 91, 1697 1700.
-
(2006)
Haematologica
, vol.91
, pp. 1697-1700
-
-
Landgren, O.1
Rapkin, J.S.2
Mellemkjaer, L.3
Gridley, G.4
Goldin, L.R.5
Engels, E.A.6
-
86
-
-
10744231369
-
Immunomodulatory drug costimulates T cells via the B7-CD28 pathway
-
LeBlanc, R., Hideshima, T., Catley, L.P., Shringarpure, R., Burger, R., Mitsiades, N., Mitsiades, C., Cheema, P., Chauhan, D., Richardson, P.G., Anderson, K.C. Munshi, N.C. (2004) Immunomodulatory drug costimulates T cells via the B7-CD28 pathway. Blood, 103, 1787 1790.
-
(2004)
Blood
, vol.103
, pp. 1787-1790
-
-
Leblanc, R.1
Hideshima, T.2
Catley, L.P.3
Shringarpure, R.4
Burger, R.5
Mitsiades, N.6
Mitsiades, C.7
Cheema, P.8
Chauhan, D.9
Richardson, P.G.10
Anderson, K.C.11
Munshi, N.C.12
-
87
-
-
0012689130
-
Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: A population-based study. Nordic Myeloma Study Group
-
for the Nordic Myeloma Study Group (
-
Lenhoff, S., Hjorth, M., Holmberg, E., Turesson, I., Westin, J., Nielsen, J.N., Wislöff, F., Brinch, L., Carlson, K., Carlsson, M., Dahl, I.M., Gimsing, P., Hippe, E., Johnsen, H., Lamvik, J., Löfvenberg, E., Nesthus, I. Rödjer, S. for the Nordic Myeloma Study Group (2000) Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study. Nordic Myeloma Study Group. Blood, 95, 7 11.
-
(2000)
Blood
, vol.95
, pp. 7-11
-
-
Lenhoff, S.1
Hjorth, M.2
Holmberg, E.3
Turesson, I.4
Westin, J.5
Nielsen, J.N.6
Wislöff, F.7
Brinch, L.8
Carlson, K.9
Carlsson, M.10
Dahl, I.M.11
Gimsing, P.12
Hippe, E.13
Johnsen, H.14
Lamvik, J.15
Löfvenberg, E.16
Nesthus, I.17
Rödjer, S.18
-
88
-
-
0032834303
-
Idiotypic protein-pulsed dendritic cell vaccination in multiple myeloma
-
Lim, S.H. Bailey-Wood, R. (1999) Idiotypic protein-pulsed dendritic cell vaccination in multiple myeloma. International Journal of Cancer, 83, 215 222.
-
(1999)
International Journal of Cancer
, vol.83
, pp. 215-222
-
-
Lim, S.H.1
Bailey-Wood, R.2
-
89
-
-
0033655655
-
Idiotype vaccination using dendritic cells after autologous peripheral blood progenitor cell transplantation for multiple myeloma
-
Liso, A., Stockerl-Goldstein, K.E., Auffermann-Gretzinger, S., Benike, C.J., Reichardt, V., van Beckhoven, A., Rajapaksa, R., Engleman, E.G., Blume, K.G. Levy, R. (2000) Idiotype vaccination using dendritic cells after autologous peripheral blood progenitor cell transplantation for multiple myeloma. Biology of Blood and Marrow Transplantation, 6, 621 627.
-
(2000)
Biology of Blood and Marrow Transplantation
, vol.6
, pp. 621-627
-
-
Liso, A.1
Stockerl-Goldstein, K.E.2
Auffermann-Gretzinger, S.3
Benike, C.J.4
Reichardt, V.5
Van Beckhoven, A.6
Rajapaksa, R.7
Engleman, E.G.8
Blume, K.G.9
Levy, R.10
-
90
-
-
0033844816
-
Donor lymphocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: Predictive factors for response and long-term outcome
-
Lokhorst, H.M., Schattenberg, A., Cornelissen, J.J., van Oers, H.M.J., Fibbe, W., Russell, I., v. d. Donk, N.W. Verdonck, L.F. (2000) Donor lymphocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: predictive factors for response and long-term outcome. Journal of Clinical Oncology, 18, 3031 3037.
-
(2000)
Journal of Clinical Oncology
, vol.18
, pp. 3031-3037
-
-
Lokhorst, H.M.1
Schattenberg, A.2
Cornelissen, J.J.3
Van Oers, H.M.J.4
Fibbe, W.5
Russell, I.6
Donk, N.W.V.D.7
Verdonck, L.F.8
-
91
-
-
33847079661
-
B7-1 and 4-1BB ligand expression on a myeloma cell line makes it possible to expand autologous tumor-specific cytotoxic T cells in vitro
-
Lu, Z.Y., Condomines, M., Tarte, K., Nadal, L., Delteil, M.C., Rossi, J.F., Ferrand, C. Klein, B. (2007) B7-1 and 4-1BB ligand expression on a myeloma cell line makes it possible to expand autologous tumor-specific cytotoxic T cells in vitro. Experimental Hematology, 35, 443 453.
-
(2007)
Experimental Hematology
, vol.35
, pp. 443-453
-
-
Lu, Z.Y.1
Condomines, M.2
Tarte, K.3
Nadal, L.4
Delteil, M.C.5
Rossi, J.F.6
Ferrand, C.7
Klein, B.8
-
92
-
-
0035422908
-
Differences in the expression of human class I MHC alleles and their associated peptides in the presence of proteasome inhibitors
-
Luckey, C.J., Marto, J.A., Partridge, M., Hall, E., White, F.M., Lippolis, J.D., Shabanowitz, J., Hunt, D.F. Engelhard, V.H. (2001) Differences in the expression of human class I MHC alleles and their associated peptides in the presence of proteasome inhibitors. Journal of Immunology, 167, 1212 1221.
-
(2001)
Journal of Immunology
, vol.167
, pp. 1212-1221
-
-
Luckey, C.J.1
Marto, J.A.2
Partridge, M.3
Hall, E.4
White, F.M.5
Lippolis, J.D.6
Shabanowitz, J.7
Hunt, D.F.8
Engelhard, V.H.9
-
93
-
-
0038268128
-
Viral antigen-specific CD8+ T-cell responses are impaired in multiple myeloma
-
Maecker, B., Anderson, K.S., von Bergwelt-Baildon, M.S., Weller, E., Vonderheide, R.H., Richardson, P.G., Schlossman, R.L., Menezes, I.A., Xia, Z., Munshi, N.C., Anderson, K.C., Nadler, L.M. Schultze, J.L. (2003) Viral antigen-specific CD8+ T-cell responses are impaired in multiple myeloma. British Journal of Haematology, 121, 842 848.
-
(2003)
British Journal of Haematology
, vol.121
, pp. 842-848
-
-
Maecker, B.1
Anderson, K.S.2
Von Bergwelt-Baildon, M.S.3
Weller, E.4
Vonderheide, R.H.5
Richardson, P.G.6
Schlossman, R.L.7
Menezes, I.A.8
Xia, Z.9
Munshi, N.C.10
Anderson, K.C.11
Nadler, L.M.12
Schultze, J.L.13
-
94
-
-
0034945969
-
Severe and long-lasting disruption of T-cell receptor diversity in human myeloma after high-dose chemotherapy and autologous peripheral blood progenitor cell infusion
-
Mariani, S., Coscia, M., Even, J., Peola, S., Foglietta, M., Boccadoro, M., Sbaiz, L., Restagno, G., Pileri, A. Massaia, M. (2001) Severe and long-lasting disruption of T-cell receptor diversity in human myeloma after high-dose chemotherapy and autologous peripheral blood progenitor cell infusion. British Journal of Haematology, 113, 1051 1059.
-
(2001)
British Journal of Haematology
, vol.113
, pp. 1051-1059
-
-
Mariani, S.1
Coscia, M.2
Even, J.3
Peola, S.4
Foglietta, M.5
Boccadoro, M.6
Sbaiz, L.7
Restagno, G.8
Pileri, A.9
Massaia, M.10
-
95
-
-
20244364254
-
Effector gammadelta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma
-
Mariani, S., Muraro, M., Pantaleoni, F., Fiore, F., Nuschak, B., Peola, S., Foglietta, M., Palumbo, A., Coscia, M., Castella, B., Bruno, B., Bertieri, R., Boano, L., Boccadoro, M. Massaia, M. (2005) Effector gammadelta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma. Leukemia, 19, 664 670.
-
(2005)
Leukemia
, vol.19
, pp. 664-670
-
-
Mariani, S.1
Muraro, M.2
Pantaleoni, F.3
Fiore, F.4
Nuschak, B.5
Peola, S.6
Foglietta, M.7
Palumbo, A.8
Coscia, M.9
Castella, B.10
Bruno, B.11
Bertieri, R.12
Boano, L.13
Boccadoro, M.14
Massaia, M.15
-
96
-
-
0036381106
-
Thalidomide and its analogues have distinct and opposing effects on TNF-alpha and TNFR2 during co-stimulation of both CD4(+) and CD8(+) T cells
-
Marriott, J.B., Clarke, I.A., Dredge, K., Muller, G., Stirling, D. Dalgleish, A.G. (2002) Thalidomide and its analogues have distinct and opposing effects on TNF-alpha and TNFR2 during co-stimulation of both CD4(+) and CD8(+) T cells. Clinical and Experimental Immunology, 130, 75 84.
-
(2002)
Clinical and Experimental Immunology
, vol.130
, pp. 75-84
-
-
Marriott, J.B.1
Clarke, I.A.2
Dredge, K.3
Muller, G.4
Stirling, D.5
Dalgleish, A.G.6
-
97
-
-
0028979456
-
Dysregulated Fas and Bcl-2 expression leading to enhanced apoptosis in T cells of multiple myeloma patients
-
Massaia, M., Borrione, P., Attisano, C., Barral, P., Beggiato, E., Montacchini, L., Bianchi, A., Boccadoro, M. Pileri, A. (1995) Dysregulated Fas and Bcl-2 expression leading to enhanced apoptosis in T cells of multiple myeloma patients. Blood, 85, 3679 3687.
-
(1995)
Blood
, vol.85
, pp. 3679-3687
-
-
Massaia, M.1
Borrione, P.2
Attisano, C.3
Barral, P.4
Beggiato, E.5
Montacchini, L.6
Bianchi, A.7
Boccadoro, M.8
Pileri, A.9
-
98
-
-
0020673510
-
Abnormal monoclonal antibody-defined helper/suppressor T-cell subpopulations in multiple myeloma: Relationship to treatment and clinical stage
-
Mills, K.H. Cawley, J.C. (1983) Abnormal monoclonal antibody-defined helper/suppressor T-cell subpopulations in multiple myeloma: relationship to treatment and clinical stage. British Journal of Haematology, 53, 271 275.
-
(1983)
British Journal of Haematology
, vol.53
, pp. 271-275
-
-
Mills, K.H.1
Cawley, J.C.2
-
99
-
-
33749439349
-
MBL2 polymorphism and risk of severe infections in multiple myeloma patients receiving high-dose melphalan and autologous stem cell transplantation
-
Molle, I., Peterslund, N.A., Thiel, S. Steffensen, R. (2006) MBL2 polymorphism and risk of severe infections in multiple myeloma patients receiving high-dose melphalan and autologous stem cell transplantation. Bone Marrow Transplantation, 38, 555 560.
-
(2006)
Bone Marrow Transplantation
, vol.38
, pp. 555-560
-
-
Molle, I.1
Peterslund, N.A.2
Thiel, S.3
Steffensen, R.4
-
100
-
-
0031573214
-
Inhibition of IL-12 production by thalidomide
-
Moller, D.R., Wysocka, M., Greenlee, B.M., Ma, X., Wahl, L., Flockhart, D.A., Trinchieri, G. Karp, C.L. (1997) Inhibition of IL-12 production by thalidomide. Journal of Immunology, 159, 5157 5161.
-
(1997)
Journal of Immunology
, vol.159
, pp. 5157-5161
-
-
Moller, D.R.1
Wysocka, M.2
Greenlee, B.M.3
Ma, X.4
Wahl, L.5
Flockhart, D.A.6
Trinchieri, G.7
Karp, C.L.8
-
101
-
-
2942564135
-
Tumor-derived MUC1 mucins interact with differentiating monocytes and induce IL-10highIL-12low regulatory dendritic cell
-
Monti, P., Leone, B.E., Zerbi, A., Balzano, G., Cainarca, S., Sordi, V., Pontillo, M., Mercalli, A., Di Carlo, V., Allavena, P. Piemonti, L. (2004) Tumor-derived MUC1 mucins interact with differentiating monocytes and induce IL-10highIL-12low regulatory dendritic cell. Journal of Immunology, 172, 7341 7349.
-
(2004)
Journal of Immunology
, vol.172
, pp. 7341-7349
-
-
Monti, P.1
Leone, B.E.2
Zerbi, A.3
Balzano, G.4
Cainarca, S.5
Sordi, V.6
Pontillo, M.7
Mercalli, A.8
Di Carlo, V.9
Allavena, P.10
Piemonti, L.11
-
102
-
-
1642348866
-
Angiogenesis-inflammation cross-talk: Vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization
-
Mor, F., Quintana, F.J. Cohen, I.R. (2004) Angiogenesis-inflammation cross-talk: vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization. Journal of Immunology, 172, 4618 4623.
-
(2004)
Journal of Immunology
, vol.172
, pp. 4618-4623
-
-
Mor, F.1
Quintana, F.J.2
Cohen, I.R.3
-
103
-
-
33749624177
-
Cancer regression in patients after transfer of genetically engineered lymphocytes
-
Morgan, R.A., Dudley, M.E., Wunderlich, J.R., Hughes, M.S., Yang, J.C., Sherry, R.M., Royal, R.E., Topalian, S.L., Kammula, U.S., Restifo, N.P., Zheng, Z., Nahvi, A., de Vries, C.R., Rogers-Freezer, L.J., Mavroukakis, S.A. Rosenberg, S.A. (2006) Cancer regression in patients after transfer of genetically engineered lymphocytes. Science, 314, 126 129.
-
(2006)
Science
, vol.314
, pp. 126-129
-
-
Morgan, R.A.1
Dudley, M.E.2
Wunderlich, J.R.3
Hughes, M.S.4
Yang, J.C.5
Sherry, R.M.6
Royal, R.E.7
Topalian, S.L.8
Kammula, U.S.9
Restifo, N.P.10
Zheng, Z.11
Nahvi, A.12
De Vries, C.R.13
Rogers-Freezer, L.J.14
Mavroukakis, S.A.15
Rosenberg, S.A.16
-
104
-
-
0029966625
-
Clonal populations of CD4+ and CD8+ T cells in patients with multiple myeloma and paraproteinemia
-
Moss, P., Gillespie, G., Frodsham, P., Bell, J. Reyburn, H. (1996) Clonal populations of CD4+ and CD8+ T cells in patients with multiple myeloma and paraproteinemia. Blood, 87, 3297 3306.
-
(1996)
Blood
, vol.87
, pp. 3297-3306
-
-
Moss, P.1
Gillespie, G.2
Frodsham, P.3
Bell, J.4
Reyburn, H.5
-
105
-
-
0842265594
-
Signalling molecules and cytokine production in T cells of multiple myeloma-increased abnormalities with advancing stage
-
Mozaffari, F., Hansson, L., Kiaii, S., Ju, X., Rossmann, E.D., Rabbani, H., Mellstedt, H. Österborg, A. (2004) Signalling molecules and cytokine production in T cells of multiple myeloma-increased abnormalities with advancing stage. British Journal of Haematology, 124, 315 324.
-
(2004)
British Journal of Haematology
, vol.124
, pp. 315-324
-
-
Mozaffari, F.1
Hansson, L.2
Kiaii, S.3
Ju, X.4
Rossmann, E.D.5
Rabbani, H.6
Mellstedt, H.7
Österborg, A.8
-
106
-
-
0036175389
-
Expression of transcription factors Pu.1, Spi-B, Blimp-1, BSAP and oct-2 in normal human plasma cells and in multiple myeloma cells
-
Nagy, M., Chapuis, B. Matthes, T. (2002) Expression of transcription factors Pu.1, Spi-B, Blimp-1, BSAP and oct-2 in normal human plasma cells and in multiple myeloma cells. British Journal of Haematology, 116, 429 435.
-
(2002)
British Journal of Haematology
, vol.116
, pp. 429-435
-
-
Nagy, M.1
Chapuis, B.2
Matthes, T.3
-
107
-
-
23944475612
-
Tumor antigen immunization of sibling stem cell transplant donors in multiple myeloma
-
Neelapu, S.S., Munshi, N.C., Jagannath, S., Watson, T.M., Pennington, R., Reynolds, C., Barlogie, B. Kwak, L.W. (2005) Tumor antigen immunization of sibling stem cell transplant donors in multiple myeloma. Bone Marrow Transplantation, 36, 315 323.
-
(2005)
Bone Marrow Transplantation
, vol.36
, pp. 315-323
-
-
Neelapu, S.S.1
Munshi, N.C.2
Jagannath, S.3
Watson, T.M.4
Pennington, R.5
Reynolds, C.6
Barlogie, B.7
Kwak, L.W.8
-
108
-
-
33845520806
-
Proteasome inhibitors: Antitumor effects and beyond
-
Nencioni, A., Grunebach, F., Patrone, F., Ballestro, A. Brossart, P. (2007) Proteasome inhibitors: antitumor effects and beyond. Leukemia, 21, 30 36.
-
(2007)
Leukemia
, vol.21
, pp. 30-36
-
-
Nencioni, A.1
Grunebach, F.2
Patrone, F.3
Ballestro, A.4
Brossart, P.5
-
109
-
-
33749647652
-
Cancer immunotherapy is more than a numbers game
-
Offringa, R. (2006) Cancer immunotherapy is more than a numbers game. Science, 314, 68 69.
-
(2006)
Science
, vol.314
, pp. 68-69
-
-
Offringa, R.1
-
110
-
-
10644224388
-
High Th1/Th2 ratio in patients with multiple myeloma
-
Ogawara, H., Handa, H., Yamazaki, T., Toda, T., Yoshida, K., Nishimoto, N., Al-ma'Quol, W., Kaneko, Y., Matsushima, T., Tsukamoto, N., Nojima, Y., Matsumoto, M., Sawamura, M. Murakami, H. (2005) High Th1/Th2 ratio in patients with multiple myeloma. Leukemia Research, 29, 135 140.
-
(2005)
Leukemia Research
, vol.29
, pp. 135-140
-
-
Ogawara, H.1
Handa, H.2
Yamazaki, T.3
Toda, T.4
Yoshida, K.5
Nishimoto, N.6
Al-Ma'Quol, W.7
Kaneko, Y.8
Matsushima, T.9
Tsukamoto, N.10
Nojima, Y.11
Matsumoto, M.12
Sawamura, M.13
Murakami, H.14
-
111
-
-
0037777538
-
VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression
-
Ohm, J.E., Gabrilovich, D.I., Sempowski, G.D., Kisseleva, E., Parman, K.S., Nadaf, S. Carbone, D.P. (2003) VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression. Blood, 101, 4878 4886.
-
(2003)
Blood
, vol.101
, pp. 4878-4886
-
-
Ohm, J.E.1
Gabrilovich, D.I.2
Sempowski, G.D.3
Kisseleva, E.4
Parman, K.S.5
Nadaf, S.6
Carbone, D.P.7
-
112
-
-
0030175914
-
Prophylactic antibiotics for the prevention of early infection in multiple myeloma
-
Oken, M., Pomeroy, C., Weisdorf, D. Bennett, J. (1996) Prophylactic antibiotics for the prevention of early infection in multiple myeloma. American Journal of Medicine, 100, 624 628.
-
(1996)
American Journal of Medicine
, vol.100
, pp. 624-628
-
-
Oken, M.1
Pomeroy, C.2
Weisdorf, D.3
Bennett, J.4
-
113
-
-
0032055911
-
Idiotype immunization combined with granulocyte-macrophage colony-stimulating factor in myeloma patients induced type I, major histocompatibility complex-restricted, CD8- and CD4-specific T-cell responses
-
Osterborg, A., Yi, Q., Henriksson, L., Fagerberg, J., Bergenbrant, S., Jedi-Tehrani, M., Ruden, U., Lefvert, A.K., Holm, G. Mellstedt, H. (1998) Idiotype immunization combined with granulocyte-macrophage colony-stimulating factor in myeloma patients induced type I, major histocompatibility complex-restricted, CD8- and CD4-specific T-cell responses. Blood, 91, 2459 2466.
-
(1998)
Blood
, vol.91
, pp. 2459-2466
-
-
Osterborg, A.1
Yi, Q.2
Henriksson, L.3
Fagerberg, J.4
Bergenbrant, S.5
Jedi-Tehrani, M.6
Ruden, U.7
Lefvert, A.K.8
Holm, G.9
Mellstedt, H.10
-
114
-
-
0036233930
-
IL-10 in myeloma cells
-
Otsuki, T., Yata, K., Sakaguchi, H., Uno, M., Fujii, T., Wada, H., Sugihara, T. Ueki, A. (2002) IL-10 in myeloma cells. Leukemia Lymphoma, 43, 969 974.
-
(2002)
Leukemia Lymphoma
, vol.43
, pp. 969-974
-
-
Otsuki, T.1
Yata, K.2
Sakaguchi, H.3
Uno, M.4
Fujii, T.5
Wada, H.6
Sugihara, T.7
Ueki, A.8
-
115
-
-
4644249098
-
IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation
-
Park, S.J., Nakagawa, T., Kitamura, H., Atsumi, T., Kamon, H., Sawa, S., Kamimura, D., Ueda, N., Iwakura, Y., Ishihara, K., Murakami, M. Hirano, T. (2004) IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation. Journal of Immunology, 173, 3844 3854.
-
(2004)
Journal of Immunology
, vol.173
, pp. 3844-3854
-
-
Park, S.J.1
Nakagawa, T.2
Kitamura, H.3
Atsumi, T.4
Kamon, H.5
Sawa, S.6
Kamimura, D.7
Ueda, N.8
Iwakura, Y.9
Ishihara, K.10
Murakami, M.11
Hirano, T.12
-
116
-
-
10344264979
-
Immunomodulatory drugs inhibit expression of cyclooxygenase-2 from TNF-alpha, IL-1beta, and LPS-stimulated human PBMC in a partially IL-10-dependent manner
-
Payvandi, F., Wu, L., Haley, M., Schafer, P.H., Zhang, L.H., Chen, R.S., Muller, G.W. Stirling, D.I. (2004) Immunomodulatory drugs inhibit expression of cyclooxygenase-2 from TNF-alpha, IL-1beta, and LPS-stimulated human PBMC in a partially IL-10-dependent manner. Cellular Immunology, 230, 81 88.
-
(2004)
Cellular Immunology
, vol.230
, pp. 81-88
-
-
Payvandi, F.1
Wu, L.2
Haley, M.3
Schafer, P.H.4
Zhang, L.H.5
Chen, R.S.6
Muller, G.W.7
Stirling, D.I.8
-
117
-
-
27244451493
-
Co-stimulatory pathways in lymphocyte regulation: The immunoglobulin superfamily
-
Peggs, K.S. Allison, J.P. (2005) Co-stimulatory pathways in lymphocyte regulation: the immunoglobulin superfamily. British Journal of Haematology, 130, 809 824.
-
(2005)
British Journal of Haematology
, vol.130
, pp. 809-824
-
-
Peggs, K.S.1
Allison, J.P.2
-
118
-
-
20144376830
-
Clonal plasma cells from monoclonal gammopathy of undetermined significance, multiple myeloma and plasma cell leukemia show different expression profiles of molecules involved in the interaction with the immunological bone marrow microenvironment
-
Pérez-Andrés, M., Almeida, J., Martín-Ayuso, M., Moro, M.J., Martín-Nuñez, G., Galende, J., Borrego, D., Rodríguez, M.J., Ortega, F., Hernandez, J., Moreno, I., Domínguez, M., Mateo, G., San Miguel, J.F. Orfao, A. (2005) Clonal plasma cells from monoclonal gammopathy of undetermined significance, multiple myeloma and plasma cell leukemia show different expression profiles of molecules involved in the interaction with the immunological bone marrow microenvironment. Leukemia, 19, 449 455.
-
(2005)
Leukemia
, vol.19
, pp. 449-455
-
-
Pérez-Andrés, M.1
Almeida, J.2
Martín-Ayuso, M.3
Moro, M.J.4
Martín-Nuñez, G.5
Galende, J.6
Borrego, D.7
Rodríguez, M.J.8
Ortega, F.9
Hernandez, J.10
Moreno, I.11
Domínguez, M.12
Mateo, G.13
San Miguel, J.F.14
Orfao, A.15
-
119
-
-
33644847914
-
Characterization of bone marrow T cells in monoclonal gammopathy of undetermined significance, multiple myeloma, and plasma cell leukemia demonstrates increased infiltration by cytotoxic/Th1 T cells demonstrating a squed TCR-Vbeta repertoire
-
Pérez-Andres, M., Almeida, J., Martin-Ayuso, M., Moro, M.J., Martin-Nuñez, G., Galende, J., Hernandez, J., Mateo, G., San Miguel, J.F. Orfao, A. (2006) Characterization of bone marrow T cells in monoclonal gammopathy of undetermined significance, multiple myeloma, and plasma cell leukemia demonstrates increased infiltration by cytotoxic/Th1 T cells demonstrating a squed TCR-Vbeta repertoire. Cancer, 106, 1296 1305.
-
(2006)
Cancer
, vol.106
, pp. 1296-1305
-
-
Pérez-Andres, M.1
Almeida, J.2
Martin-Ayuso, M.3
Moro, M.J.4
Martin-Nuñez, G.5
Galende, J.6
Hernandez, J.7
Mateo, G.8
San Miguel, J.F.9
Orfao, A.10
-
120
-
-
0019825038
-
Influence of treatment and response status on infection risk in multiple myeloma
-
Perri, R.T., Hebbel, R.P. Oken, M.M. (1981) Influence of treatment and response status on infection risk in multiple myeloma. American Journal of Medicine, 71, 935 940.
-
(1981)
American Journal of Medicine
, vol.71
, pp. 935-940
-
-
Perri, R.T.1
Hebbel, R.P.2
Oken, M.M.3
-
121
-
-
0038153907
-
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma
-
Phan, G.Q., Yang, J.C., Sherry, R.M., Hwu, P., Topalian, S.L., Schwartzentruber, D.J., Restifo, N.P., Haworth, L.R., Seipp, C.A., Freezer, L.J., Morton, K.E., Mavroukakis, S.A., Duray, P.H., Steinberg, S.M., Allison, J.P., Davis, T.A. Rosenberg, S.A. (2003) Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proceedings of the National Academy of scientists U S A, 100, 8372 8377.
-
(2003)
Proceedings of the National Academy of Scientists U S a
, vol.100
, pp. 8372-8377
-
-
Phan, G.Q.1
Yang, J.C.2
Sherry, R.M.3
Hwu, P.4
Topalian, S.L.5
Schwartzentruber, D.J.6
Restifo, N.P.7
Haworth, L.R.8
Seipp, C.A.9
Freezer, L.J.10
Morton, K.E.11
Mavroukakis, S.A.12
Duray, P.H.13
Steinberg, S.M.14
Allison, J.P.15
Davis, T.A.16
Rosenberg, S.A.17
-
122
-
-
13544255403
-
The pathophysiologic role of VEGF in hematologic malignancies: Therapeutic implications
-
Podar, K. Anderson, K.C. (2005) The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications. Blood, 105, 383 1395.
-
(2005)
Blood
, vol.105
, pp. 383-1395
-
-
Podar, K.1
Anderson, K.C.2
-
123
-
-
0035437134
-
Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma
-
Porrata, L.F., Gertz, M.A., Inwards, D.J., Litzow, M.R., Lacy, M.Q., Tefferi, A., Gastineau, D., Dispenzieri, A., Ansell, S.M., Micallef, I.N., Geyer, S.M. Markovic, S.N. (2001) Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma. Blood, 98, 579 585.
-
(2001)
Blood
, vol.98
, pp. 579-585
-
-
Porrata, L.F.1
Gertz, M.A.2
Inwards, D.J.3
Litzow, M.R.4
Lacy, M.Q.5
Tefferi, A.6
Gastineau, D.7
Dispenzieri, A.8
Ansell, S.M.9
Micallef, I.N.10
Geyer, S.M.11
Markovic, S.N.12
-
124
-
-
2942638133
-
The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma
-
Porrata, L.F., Gertz, M.A., Geyer, S.M., Litzow, M.R., Gastineau, D.A., Moore, S.B., Pineda, A.A., Bundy, K.L., Padley, D.J., Persky, D., Lacy, M.Q., Dispenzieri, A., Snow, D.S. Markovic, S.N. (2004) The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma. Leukemia, 18, 1085 1092.
-
(2004)
Leukemia
, vol.18
, pp. 1085-1092
-
-
Porrata, L.F.1
Gertz, M.A.2
Geyer, S.M.3
Litzow, M.R.4
Gastineau, D.A.5
Moore, S.B.6
Pineda, A.A.7
Bundy, K.L.8
Padley, D.J.9
Persky, D.10
Lacy, M.Q.11
Dispenzieri, A.12
Snow, D.S.13
Markovic, S.N.14
-
125
-
-
30144444962
-
Dysfunctional T regulatory cells in multiple myeloma
-
Prabhala, R.H., Neri, P., Bae, J.E., Tassone, P., Shammas, M.A., Allam, C.K., Daley, J.F., Chauhan, D., Blanchard, E., Thatte, H.S., Anderson, K.C. Munshi, N.C. (2006) Dysfunctional T regulatory cells in multiple myeloma. Blood, 107, 301 304.
-
(2006)
Blood
, vol.107
, pp. 301-304
-
-
Prabhala, R.H.1
Neri, P.2
Bae, J.E.3
Tassone, P.4
Shammas, M.A.5
Allam, C.K.6
Daley, J.F.7
Chauhan, D.8
Blanchard, E.9
Thatte, H.S.10
Anderson, K.C.11
Munshi, N.C.12
-
126
-
-
33750565570
-
Erythropoietin treatment in advanced multiple myeloma is associated with improved immunological functions: Could it be beneficial in early disease?
-
Prutchi-Sagiv, S., Golishevsky, N., Oster, H.S., Katz, O., Cohen, A., Naparstek, E., Neumann, D. Mittelman, M. (2006) Erythropoietin treatment in advanced multiple myeloma is associated with improved immunological functions: could it be beneficial in early disease? British Journal of Haematology, 135, 660 672.
-
(2006)
British Journal of Haematology
, vol.135
, pp. 660-672
-
-
Prutchi-Sagiv, S.1
Golishevsky, N.2
Oster, H.S.3
Katz, O.4
Cohen, A.5
Naparstek, E.6
Neumann, D.7
Mittelman, M.8
-
127
-
-
3042599187
-
Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant
-
Qiyuan, C., Jackson, H., Parente, P., Luke, T., Rizkalla, M., Tai, T.Y., Zhu, H.C., Mifsud, N.A., Dimopoulos, N., Masterman, K.A., Hopkins, W., Goldie, H., Maraskovsky, E., Green, S., Miloradovic, L., McCluskey, J., Old, L.J., Davis, I.D., Cebon, J. Weisan, C. (2004) Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant. Proceedings of the National Academy of scientists U S A, 101, 9363 9368.
-
(2004)
Proceedings of the National Academy of Scientists U S a
, vol.101
, pp. 9363-9368
-
-
Qiyuan, C.1
Jackson, H.2
Parente, P.3
Luke, T.4
Rizkalla, M.5
Tai, T.Y.6
Zhu, H.C.7
Mifsud, N.A.8
Dimopoulos, N.9
Masterman, K.A.10
Hopkins, W.11
Goldie, H.12
Maraskovsky, E.13
Green, S.14
Miloradovic, L.15
McCluskey, J.16
Old, L.J.17
Davis, I.D.18
Cebon, J.19
Weisan, C.20
more..
-
128
-
-
0037347240
-
T cells in myeloma
-
Raitakari, M., Brown, R.D., Gibson, J. Joshua, D.E. (2003) T cells in myeloma. Hematology Oncology, 21, 33 42.
-
(2003)
Hematology Oncology
, vol.21
, pp. 33-42
-
-
Raitakari, M.1
Brown, R.D.2
Gibson, J.3
Joshua, D.E.4
-
129
-
-
0036843032
-
Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma
-
Rajkumar, S.V., Hayman, S., Gertz, M.A., Dispenzieri, A., Lacy, M.Q., Greipp, P.R., Geyer, S., Iturria, N., Fonseca, R., Lust, J.A., Kyle, R.A. Witzig, T.E. (2002) Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma. Journal of Clinical Oncology, 20, 4319 4323.
-
(2002)
Journal of Clinical Oncology
, vol.20
, pp. 4319-4323
-
-
Rajkumar, S.V.1
Hayman, S.2
Gertz, M.A.3
Dispenzieri, A.4
Lacy, M.Q.5
Greipp, P.R.6
Geyer, S.7
Iturria, N.8
Fonseca, R.9
Lust, J.A.10
Kyle, R.A.11
Witzig, T.E.12
-
130
-
-
30744454570
-
Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer
-
Rapoport, A.P., Stadtmauer, E.A., Aqui, N., Badros, A., Cotte, J., Chrisley, L., Veloso, E., Zheng, Z., Westphal, S., Mair, R., Chi, N., Ratterree, B., Pochran, M.F., Natt, S., Hinkle, J., Sickles, C., Sohal, A., Ruehle, K., Lynch, C., Zhang, L., Porter, D.L., Luger, S., Guo, C., Fang, H., Blackwelder, W., Hankey, K., Mann, D., Edelman, R., Frasch, C., Levine, B.L., Cross, A. June, C.H. (2005) Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer. Nature Medicine, 11, 1230 1237.
-
(2005)
Nature Medicine
, vol.11
, pp. 1230-1237
-
-
Rapoport, A.P.1
Stadtmauer, E.A.2
Aqui, N.3
Badros, A.4
Cotte, J.5
Chrisley, L.6
Veloso, E.7
Zheng, Z.8
Westphal, S.9
Mair, R.10
Chi, N.11
Ratterree, B.12
Pochran, M.F.13
Natt, S.14
Hinkle, J.15
Sickles, C.16
Sohal, A.17
Ruehle, K.18
Lynch, C.19
Zhang, L.20
Porter, D.L.21
Luger, S.22
Guo, C.23
Fang, H.24
Blackwelder, W.25
Hankey, K.26
Mann, D.27
Edelman, R.28
Frasch, C.29
Levine, B.L.30
Cross, A.31
June, C.H.32
more..
-
131
-
-
0037804767
-
Idiotype vaccination in multiple myeloma induced a reduction of circulating clonal tumor B cells
-
Rasmussen, T., Hansson, L., Österborg, A., Johnsen, H.E. Mellstedt, H. (2003) Idiotype vaccination in multiple myeloma induced a reduction of circulating clonal tumor B cells. Blood, 101, 4607 4610.
-
(2003)
Blood
, vol.101
, pp. 4607-4610
-
-
Rasmussen, T.1
Hansson, L.2
Österborg, A.3
Johnsen, H.E.4
Mellstedt, H.5
-
132
-
-
0036659945
-
Dendritic cells are functionally defective in multiple myeloma: The role of interleukin-6
-
Ratta, M., Fagnoni, F., Curti, A., Vescovini, R., Sansoni, P., Oliviero, B., Fogli, M., Ferri, E., Della Cuna, G.R., Tura, S., Baccarani, M. Lemoli, R.M. (2002) Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6. Blood, 100, 230 237.
-
(2002)
Blood
, vol.100
, pp. 230-237
-
-
Ratta, M.1
Fagnoni, F.2
Curti, A.3
Vescovini, R.4
Sansoni, P.5
Oliviero, B.6
Fogli, M.7
Ferri, E.8
Della Cuna, G.R.9
Tura, S.10
Baccarani, M.11
Lemoli, R.M.12
-
133
-
-
0031961959
-
B-lymphocyte suppression in multiple myeloma is a reversible phenomenon specific to normal B-cell progenitors and plasma cell precursors
-
Rawstron, A.C., Davies, F.E., Owen, R.G., English, A., Pratt, G., Child, J.A., Jack, A.S. Morgan, G.J. (1998) B-lymphocyte suppression in multiple myeloma is a reversible phenomenon specific to normal B-cell progenitors and plasma cell precursors. British Journal of Haematology, 100, 176 183.
-
(1998)
British Journal of Haematology
, vol.100
, pp. 176-183
-
-
Rawstron, A.C.1
Davies, F.E.2
Owen, R.G.3
English, A.4
Pratt, G.5
Child, J.A.6
Jack, A.S.7
Morgan, G.J.8
-
134
-
-
0025859580
-
Perspectives in multiple myeloma survival, prognostic factors and disease complications in a single centre between 1975 and 1988
-
Rayner, H.C., Haynes, A.P., Thompson, J.R., Russell, N. Fletcher, J. (1991). Perspectives in multiple myeloma survival, prognostic factors and disease complications in a single centre between 1975 and 1988. Quarterly Journal of Medicine, 79, 517 525.
-
(1991)
Quarterly Journal of Medicine
, vol.79
, pp. 517-525
-
-
Rayner, H.C.1
Haynes, A.P.2
Thompson, J.R.3
Russell, N.4
Fletcher, J.5
-
135
-
-
0033120389
-
Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma - A feasibility study
-
Reichardt, V.L., Okada, C.Y., Liso, A., Benike, C.J., Stockerl-Goldstein, K.E., Engleman, E.G., Blume, K.G. Levy, R. (1999) Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma - a feasibility study. Blood, 93, 2411 2419.
-
(1999)
Blood
, vol.93
, pp. 2411-2419
-
-
Reichardt, V.L.1
Okada, C.Y.2
Liso, A.3
Benike, C.J.4
Stockerl-Goldstein, K.E.5
Engleman, E.G.6
Blume, K.G.7
Levy, R.8
-
136
-
-
0242330773
-
Idiotype vaccination of multiple myeloma zpatients using monocyte-derived dendritic cells
-
Reichardt, V.L., Milazzo, C., Brugger, W., Einsele, H., Kanz, L. Brossart, P. (2003) Idiotype vaccination of multiple myeloma zpatients using monocyte-derived dendritic cells. Haematologica, 88, 1139 1149.
-
(2003)
Haematologica
, vol.88
, pp. 1139-1149
-
-
Reichardt, V.L.1
Milazzo, C.2
Brugger, W.3
Einsele, H.4
Kanz, L.5
Brossart, P.6
-
137
-
-
0035525742
-
Persistent preswitch clonotypic myeloma cells correlate with decreased survival: Evidence for isotype switching within the myeloma clone
-
Reiman, T., Seeberger, K., Taylor, B.J., Szczepek, A.J., Hanson, J., Mant, M.J., Coupland, R.W., Belch, A.R. Pilarski, L.M. (2001) Persistent preswitch clonotypic myeloma cells correlate with decreased survival: evidence for isotype switching within the myeloma clone. Blood, 98, 2791 2799.
-
(2001)
Blood
, vol.98
, pp. 2791-2799
-
-
Reiman, T.1
Seeberger, K.2
Taylor, B.J.3
Szczepek, A.J.4
Hanson, J.5
Mant, M.J.6
Coupland, R.W.7
Belch, A.R.8
Pilarski, L.M.9
-
138
-
-
20844432364
-
NY-ESO-1 is highly expressed in poor-prognosis multiple myeloma and induces spontaneous humoral and cellular immune responses
-
van Rhee, F., Szmania, S.M., Zhan, F., Gupta, S.K., Pomtree, M., Lin, P., Batchu, R.B., Moreno, A., Spagnoli, G., Shaughnessy, J. Tricot, G. (2005) NY-ESO-1 is highly expressed in poor-prognosis multiple myeloma and induces spontaneous humoral and cellular immune responses. Blood, 105, 3939 3944.
-
(2005)
Blood
, vol.105
, pp. 3939-3944
-
-
Van Rhee, F.1
Szmania, S.M.2
Zhan, F.3
Gupta, S.K.4
Pomtree, M.5
Lin, P.6
Batchu, R.B.7
Moreno, A.8
Spagnoli, G.9
Shaughnessy, J.10
Tricot, G.11
-
139
-
-
33750607347
-
A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma
-
Richardson, P.G., Blood, E., Mitsiades, C.S., Jagannath, S., Zeldenrust, S.R., Alsina, M., Schlossman, R.L., Rajkumar, S.V., Desikan, K.R., Hideshima, T., Munshi, N.C., Kelly-Colson, K., Doss, D., McKenney, M.L., Gorelik, S., Warren, D., Freeman, A., Rich, R., Wu, A., Olesnyckyj, M., Wride, K., Dalton, W.S., Zeldis, J., Knight, R., Weller, E. Anderson, K.C. (2006) A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma. Blood, 108, 3458 3464.
-
(2006)
Blood
, vol.108
, pp. 3458-3464
-
-
Richardson, P.G.1
Blood, E.2
Mitsiades, C.S.3
Jagannath, S.4
Zeldenrust, S.R.5
Alsina, M.6
Schlossman, R.L.7
Rajkumar, S.V.8
Desikan, K.R.9
Hideshima, T.10
Munshi, N.C.11
Kelly-Colson, K.12
Doss, D.13
McKenney, M.L.14
Gorelik, S.15
Warren, D.16
Freeman, A.17
Rich, R.18
Wu, A.19
Olesnyckyj, M.20
Wride, K.21
Dalton, W.S.22
Zeldis, J.23
Knight, R.24
Weller, E.25
Anderson, K.C.26
more..
-
140
-
-
0034017680
-
Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma
-
Robertson, J.D., Nagesh, K., Jowitt, S.N., Dougal, M., Anderson, H., Mutton, K., Zambon, M. Scarffe, J.H. (2000) Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma. British Journal of Cancer, 82, 1261 1265.
-
(2000)
British Journal of Cancer
, vol.82
, pp. 1261-1265
-
-
Robertson, J.D.1
Nagesh, K.2
Jowitt, S.N.3
Dougal, M.4
Anderson, H.5
Mutton, K.6
Zambon, M.7
Scarffe, J.H.8
-
141
-
-
20444403424
-
Recombinant tumor-associated MUC1 glycoprotein impairs the differentiation and function of dendritic cells
-
Rughetti, A., Pellicciotta, I., Biffoni, M., Bäckström, M., Link, T., Bennet, E.P., Clausen, H., Noll, T., Hansson, G.C., Burchell, J.M., Frati, L., Taylor-Papadimitriou, J. Nuti, M. (2005) Recombinant tumor-associated MUC1 glycoprotein impairs the differentiation and function of dendritic cells. Journal of Immunology, 174, 7764 7772.
-
(2005)
Journal of Immunology
, vol.174
, pp. 7764-7772
-
-
Rughetti, A.1
Pellicciotta, I.2
Biffoni, M.3
Bäckström, M.4
Link, T.5
Bennet, E.P.6
Clausen, H.7
Noll, T.8
Hansson, G.C.9
Burchell, J.M.10
Frati, L.11
Taylor-Papadimitriou, J.12
Nuti, M.13
-
142
-
-
0014213602
-
Role of gamma globulin for immunoprophylaxis in multiple myeloma
-
Salmon, S.E., Samal, B.A., Hayes, D.M., Hosley, H., Miller, S.P. Schilling, A. (1967) Role of gamma globulin for immunoprophylaxis in multiple myeloma. New England Journal of Medicine, 277, 1336 1340.
-
(1967)
New England Journal of Medicine
, vol.277
, pp. 1336-1340
-
-
Salmon, S.E.1
Samal, B.A.2
Hayes, D.M.3
Hosley, H.4
Miller, S.P.5
Schilling, A.6
-
143
-
-
0026080801
-
Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes
-
Sampaio, E.P., Sarno, E.N., Galilly, R., Cohn, Z.A. Kaplan, G. (1991) Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes. Journal of Experimental Medicine, 173, 699 703.
-
(1991)
Journal of Experimental Medicine
, vol.173
, pp. 699-703
-
-
Sampaio, E.P.1
Sarno, E.N.2
Galilly, R.3
Cohn, Z.A.4
Kaplan, G.5
-
144
-
-
20044395957
-
Autoimmunity in a phase I trial of a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody with multiple melanoma peptides and Montanide ISA 51 for patients with resected stages III and IV melanoma
-
Sanderson, K., Scotland, R., Lee, P., Liu, D., Groshen, S., Snively, J., Sian, S., Nichol, G., Davis, T., Keler, T., Yellin, M. Weber, J. (2005) Autoimmunity in a phase I trial of a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody with multiple melanoma peptides and Montanide ISA 51 for patients with resected stages III and IV melanoma. Journal of Clinical Oncology, 23, 741 750.
-
(2005)
Journal of Clinical Oncology
, vol.23
, pp. 741-750
-
-
Sanderson, K.1
Scotland, R.2
Lee, P.3
Liu, D.4
Groshen, S.5
Snively, J.6
Sian, S.7
Nichol, G.8
Davis, T.9
Keler, T.10
Yellin, M.11
Weber, J.12
-
145
-
-
0020062995
-
Biphasic pattern of bacterial infection in multiple myeloma
-
Savage, D.G., Lindenbaum, J. Garrett, T.J. (1982) Biphasic pattern of bacterial infection in multiple myeloma. Annals of Internal Medicine, 96, 47 50.
-
(1982)
Annals of Internal Medicine
, vol.96
, pp. 47-50
-
-
Savage, D.G.1
Lindenbaum, J.2
Garrett, T.J.3
-
146
-
-
23144464171
-
Cancer/testis antigens, gametogenesis and cancer
-
Simpson, A.J.G., Caballero, O.L., Jungbluth, A., Chen, Y.T. Old, L.J. (2005) Cancer/testis antigens, gametogenesis and cancer. Nature Reviews Cancer, 5, 615 625.
-
(2005)
Nature Reviews Cancer
, vol.5
, pp. 615-625
-
-
Simpson, A.J.G.1
Caballero, O.L.2
Jungbluth, A.3
Chen, Y.T.4
Old, L.J.5
-
147
-
-
0032748385
-
Antitumor activity of thalidomide in refractory multiple myeloma
-
Singhal, S., Mehta, J., Desikan, R., Ayers, D., Roberson, P., Eddlemon, P., Munshi, N., Anaissie, E., Wilson, C., Dhodapkar, M., Zeddis, J. Barlogie, B. (1999) Antitumor activity of thalidomide in refractory multiple myeloma. New England Journal of Medicine, 341, 1565 1571.
-
(1999)
New England Journal of Medicine
, vol.341
, pp. 1565-1571
-
-
Singhal, S.1
Mehta, J.2
Desikan, R.3
Ayers, D.4
Roberson, P.5
Eddlemon, P.6
Munshi, N.7
Anaissie, E.8
Wilson, C.9
Dhodapkar, M.10
Zeddis, J.11
Barlogie, B.12
-
148
-
-
33644869566
-
Guidelines on the diagnosis and management of multiple myeloma 2005
-
Smith, A., Wisloff, F. Samson, D. (2006) Guidelines on the diagnosis and management of multiple myeloma 2005. British Journal of Haematology, 132, 410 451.
-
(2006)
British Journal of Haematology
, vol.132
, pp. 410-451
-
-
Smith, A.1
Wisloff, F.2
Samson, D.3
-
149
-
-
34247339604
-
Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathy
-
Spisek, R., Kukreja, A., Chen, L.C., Matthews, P., Mazumder, A., Vesole, D., Jagannath, S., Zebroski, H.A., Simpson, A.J.G., Ritter, G., Durie, B., Crowley, J., Shaughnessy, J.D., Scanlan, M.J., Gure, A.O., Barlogie, B. Dhodapkar, M.V. (2007) Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathy. Journal of Experimental Medicine, 204, 831 840
-
(2007)
Journal of Experimental Medicine
, vol.204
, pp. 831-840
-
-
Spisek, R.1
Kukreja, A.2
Chen, L.C.3
Matthews, P.4
Mazumder, A.5
Vesole, D.6
Jagannath, S.7
Zebroski, H.A.8
Simpson, A.J.G.9
Ritter, G.10
Durie, B.11
Crowley, J.12
Shaughnessy, J.D.13
Scanlan, M.J.14
Gure, A.O.15
Barlogie, B.16
Dhodapkar, M.V.17
-
150
-
-
33748189347
-
Cell-surface association between matrix metalloproteinases and integrins: Role of the complexes in leukocyte migration and cancer progression
-
Stefanidakis, M. Koivunen, E. (2006) Cell-surface association between matrix metalloproteinases and integrins: role of the complexes in leukocyte migration and cancer progression. Blood, 108, 1441 1450.
-
(2006)
Blood
, vol.108
, pp. 1441-1450
-
-
Stefanidakis, M.1
Koivunen, E.2
-
151
-
-
5144221893
-
DNA vaccines to attack cancer
-
Stevenson, F.K., Ottensmeier, C.H., Johnson, P., Zhu, D., Buchan, S.L., McCann, K.J., Roddick, J.S., King, A.T., McNicholl, F., Savelyeva, N. Rice, J. (2004) DNA vaccines to attack cancer. Proceedings of the National Academy of Scientists U S A, 101 (Suppl. 2 14646 14652.
-
(2004)
Proceedings of the National Academy of Scientists U S a
, vol.101
, Issue.2
, pp. 14646-14652
-
-
Stevenson, F.K.1
Ottensmeier, C.H.2
Johnson, P.3
Zhu, D.4
Buchan, S.L.5
McCann, K.J.6
Roddick, J.S.7
King, A.T.8
McNicholl, F.9
Savelyeva, N.10
Rice, J.11
-
152
-
-
0032531999
-
A high frequency of circulating B cells share clonotypic IgH VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single cell and in situ RT-PCR
-
Szczepek, A.J., Seeberger, K., Wizniak, J., Mant, M.J., Belch, A.R. Pilarski, L.M. (1998) A high frequency of circulating B cells share clonotypic IgH VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single cell and in situ RT-PCR. Blood, 92, 2844 2855.
-
(1998)
Blood
, vol.92
, pp. 2844-2855
-
-
Szczepek, A.J.1
Seeberger, K.2
Wizniak, J.3
Mant, M.J.4
Belch, A.R.5
Pilarski, L.M.6
-
153
-
-
29244488561
-
Immunomodulatory drug lenalidomide (CC-5013, IMiD3) augments anti-CD40 SGN-40-induced cytotoxicity in human multiple myeloma: Clinical implications
-
Tai, Y.T., Li, X.F., Catley, L., Coffey, R., Breitkreutz, I., Bae, J., Song, W., Podar, K., Hideshima, T., Chauhan, D., Schlossman, R., Richardson, P., Treon, S.P., Grewal, I.S., Munshi, N.C. Anderson, K.C. (2005) Immunomodulatory drug lenalidomide (CC-5013, IMiD3) augments anti-CD40 SGN-40-induced cytotoxicity in human multiple myeloma: clinical implications. Cancer Research, 65, 11712 11720.
-
(2005)
Cancer Research
, vol.65
, pp. 11712-11720
-
-
Tai, Y.T.1
Li, X.F.2
Catley, L.3
Coffey, R.4
Breitkreutz, I.5
Bae, J.6
Song, W.7
Podar, K.8
Hideshima, T.9
Chauhan, D.10
Schlossman, R.11
Richardson, P.12
Treon, S.P.13
Grewal, I.S.14
Munshi, N.C.15
Anderson, K.C.16
-
154
-
-
2542470851
-
Vascular endothelial growth factor inhibits maturation of dendritic cells induced by lipopolysaccharide, but not by proinflammatory cytokines
-
Takahashi, A., Kono, K., Ichihara, F., Sugai, H., Fujii, H. Matsumoto, Y. (2004) Vascular endothelial growth factor inhibits maturation of dendritic cells induced by lipopolysaccharide, but not by proinflammatory cytokines. Cancer Immunology, Immunotherapy, 53, 543 550.
-
(2004)
Cancer Immunology, Immunotherapy
, vol.53
, pp. 543-550
-
-
Takahashi, A.1
Kono, K.2
Ichihara, F.3
Sugai, H.4
Fujii, H.5
Matsumoto, Y.6
-
155
-
-
27444433159
-
SSX cancer testis antigens are expressed in most multiple myeloma patients: Co-expression of SSX1, 2, 4, and 5 correlates with adverse prognosis and high frequencies of SSX-positive PCs
-
Taylor, B.J., Reiman, T., Pittman, J.A., Keats, J.J., de Bruin, D.R., Mant, M.J., Belch, A.R. Pilarski, L.M. (2005) SSX cancer testis antigens are expressed in most multiple myeloma patients: co-expression of SSX1, 2, 4, and 5 correlates with adverse prognosis and high frequencies of SSX-positive PCs. Journal of Immunotherapy, 28, 564 575.
-
(2005)
Journal of Immunotherapy
, vol.28
, pp. 564-575
-
-
Taylor, B.J.1
Reiman, T.2
Pittman, J.A.3
Keats, J.J.4
De Bruin, D.R.5
Mant, M.J.6
Belch, A.R.7
Pilarski, L.M.8
-
156
-
-
27644457376
-
TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance
-
Thomas, D.A. Massague, J. (2005) TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance. Cancer Cell, 8, 369 380.
-
(2005)
Cancer Cell
, vol.8
, pp. 369-380
-
-
Thomas, D.A.1
Massague, J.2
-
157
-
-
30444431620
-
Alkylamines cause Vgamma9Vdelta2 T-cell activation and proliferation by inhibiting the mevalonate pathway
-
Thompson, K., Rojas-Navea, J. Rogers, M.J. (2006) Alkylamines cause Vgamma9Vdelta2 T-cell activation and proliferation by inhibiting the mevalonate pathway. Blood, 107, 651 654.
-
(2006)
Blood
, vol.107
, pp. 651-654
-
-
Thompson, K.1
Rojas-Navea, J.2
Rogers, M.J.3
-
158
-
-
0034025657
-
Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: Immunological and clinical aspects
-
Titzer, S., Chrsitensen, O., Manzke, O., Tesch, H., Wolf, J., Emmerich, B., Carsten, C., Diehl, V. Bohlen, H. (2000) Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects. British Journal of Haematology, 108, 805 816.
-
(2000)
British Journal of Haematology
, vol.108
, pp. 805-816
-
-
Titzer, S.1
Chrsitensen, O.2
Manzke, O.3
Tesch, H.4
Wolf, J.5
Emmerich, B.6
Carsten, C.7
Diehl, V.8
Bohlen, H.9
-
159
-
-
0030026437
-
Transforming growth factor-beta1: Differential effects on multiple myeloma versus normal B cells
-
Urashima, M., Ogata, A., Chauhan, D., Hatziyanni, M., Vidriales, M.B., Dedera, D.A., Schlossman, R.L. Anderson, K.C. (1996) Transforming growth factor-beta1: differential effects on multiple myeloma versus normal B cells. Blood, 87, 1928 1938.
-
(1996)
Blood
, vol.87
, pp. 1928-1938
-
-
Urashima, M.1
Ogata, A.2
Chauhan, D.3
Hatziyanni, M.4
Vidriales, M.B.5
Dedera, D.A.6
Schlossman, R.L.7
Anderson, K.C.8
-
160
-
-
0033840388
-
A single oral dose of thalidomide enhances the capacity of lymphocytes to secrete gamma interferon in healthy humans
-
Verbon, A., Juffermans, N.P., Speelman, P., van Deventer, S.J., ten Berge, I.J., Guchelaar, H.J. van der Poll T. (2000) A single oral dose of thalidomide enhances the capacity of lymphocytes to secrete gamma interferon in healthy humans. Antimicrobial Agents and Chemotherapy, 44, 2286 2290.
-
(2000)
Antimicrobial Agents and Chemotherapy
, vol.44
, pp. 2286-2290
-
-
Verbon, A.1
Juffermans, N.P.2
Speelman, P.3
Van Deventer, S.J.4
Ten Berge, I.J.5
Guchelaar, H.J.6
Van Der Poll, T.7
-
161
-
-
0030959255
-
Constitutive expression of Fas (Apo-1/CD95) ligand on multiple myeloma cells: A potential mechanism of tumor-induced suppression of immune surveillance
-
Villunger, A., Egle, A., Marschitz, I., Kos, M., Böck, G., Ludwig, H., Geley, S., Kofler, R. Greil, R. (1997) Constitutive expression of Fas (Apo-1/CD95) ligand on multiple myeloma cells: a potential mechanism of tumor-induced suppression of immune surveillance. Blood, 90, 12 20.
-
(1997)
Blood
, vol.90
, pp. 12-20
-
-
Villunger, A.1
Egle, A.2
Marschitz, I.3
Kos, M.4
Böck, G.5
Ludwig, H.6
Geley, S.7
Kofler, R.8
Greil, R.9
-
162
-
-
11144357779
-
Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells
-
Wang, T., Niu, G., Kortylewski, M., Burdelya, L., Shain, K., Zhang, S., Bhattacharya, R., Gabrilovich, D., Heller, R., Coppola, D., Dalton, W., Jove, R., Pardoll, D. Yu, H. (2004) Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nature Medicine, 10, 48 54.
-
(2004)
Nature Medicine
, vol.10
, pp. 48-54
-
-
Wang, T.1
Niu, G.2
Kortylewski, M.3
Burdelya, L.4
Shain, K.5
Zhang, S.6
Bhattacharya, R.7
Gabrilovich, D.8
Heller, R.9
Coppola, D.10
Dalton, W.11
Jove, R.12
Pardoll, D.13
Yu, H.14
-
163
-
-
33644757687
-
Tumor evasion of the immune system: Inhibiting p38 MAPK signaling restores the function of dendritic cells in multiple myeloma
-
Wang, S., Yang, J., Qian, J., Wezeman, W., Kwak, L. Yi, Q. (2006a) Tumor evasion of the immune system: inhibiting p38 MAPK signaling restores the function of dendritic cells in multiple myeloma. Blood, 107, 2432 2439.
-
(2006)
Blood
, vol.107
, pp. 2432-2439
-
-
Wang, S.1
Yang, J.2
Qian, J.3
Wezeman, W.4
Kwak, L.5
Yi, Q.6
-
164
-
-
33845482670
-
Optimizing immunotherapy in multiple myeloma: Restoring the function of patients' monocyte-derived dendritic cells by inhibiting p38 or activating MEK/ERK MAPK and neutralizing interleukin-6 in progenitor cells
-
Wang, S., Hong, S., Yang, J., Qian, J., Zhang, X., Shpall, E., Kwak, L.W. Yi, Q. (2006b) Optimizing immunotherapy in multiple myeloma: Restoring the function of patients' monocyte-derived dendritic cells by inhibiting p38 or activating MEK/ERK MAPK and neutralizing interleukin-6 in progenitor cells. Blood, 108, 4071 4077.
-
(2006)
Blood
, vol.108
, pp. 4071-4077
-
-
Wang, S.1
Hong, S.2
Yang, J.3
Qian, J.4
Zhang, X.5
Shpall, E.6
Kwak, L.W.7
Yi, Q.8
-
165
-
-
33748940534
-
Lenalidomide plus high-dose dexamethasone provides improved overall survival compared to high-dose dexamethasone alone for relapsed or refractory multiple myeloma (MM): Results of a North American phase III study (MM-009)
-
Abstract 7521.
-
Weber, D.M., Chen, C., Niesvizky, R., Wang, M., Belch, A., Stadtmauer, E., YuZ Olesnyckyj, M., Zeldis, J. Knight, R. (2006) Lenalidomide plus high-dose dexamethasone provides improved overall survival compared to high-dose dexamethasone alone for relapsed or refractory multiple myeloma (MM): Results of a North American phase III study (MM-009). Journal of Clinical Oncology, 24, Abstract 7521.
-
(2006)
Journal of Clinical Oncology
, vol.24
-
-
Weber, D.M.1
Chen, C.2
Niesvizky, R.3
Wang, M.4
Belch, A.5
Stadtmauer, E.6
Yuz Olesnyckyj, M.7
Zeldis, J.8
Knight, R.9
-
166
-
-
0035869383
-
Idiotype-specific cytotoxic T lymphocytes in multiple myeloma: Evidence for their capacity to lyse autologous primary tumor cells
-
Wen, Y.J., Barlogie, B. Yi, Q. (2001) Idiotype-specific cytotoxic T lymphocytes in multiple myeloma: evidence for their capacity to lyse autologous primary tumor cells. Blood, 97, 1750 1755.
-
(2001)
Blood
, vol.97
, pp. 1750-1755
-
-
Wen, Y.J.1
Barlogie, B.2
Yi, Q.3
-
167
-
-
0037968274
-
Gammadelta T cells for immune therapy of patients with lymphoid malignancies
-
Wilhelm, M., Kunzmann, V., Eckstein, S., Reimer, P., Weissinger, F., Ruediger, T. Tony, H.P. (2003) Gammadelta T cells for immune therapy of patients with lymphoid malignancies. Blood, 102, 200 206.
-
(2003)
Blood
, vol.102
, pp. 200-206
-
-
Wilhelm, M.1
Kunzmann, V.2
Eckstein, S.3
Reimer, P.4
Weissinger, F.5
Ruediger, T.6
Tony, H.P.7
-
168
-
-
33947575824
-
FcgammaRIIb controls bone marrow plasma cell persistence and apoptosis
-
Xiang, Z., Cutler, A.J., Brownlie, R.J., Fairfax, K., Lawlor, K.E., Severinson, E., Walker, E.U., Manz, R.A., Tarlington, D.M. Smith, K.G. (2007) FcgammaRIIb controls bone marrow plasma cell persistence and apoptosis. Nature Immunology, 8, 419 429.
-
(2007)
Nature Immunology
, vol.8
, pp. 419-429
-
-
Xiang, Z.1
Cutler, A.J.2
Brownlie, R.J.3
Fairfax, K.4
Lawlor, K.E.5
Severinson, E.6
Walker, E.U.7
Manz, R.A.8
Tarlington, D.M.9
Smith, K.G.10
-
169
-
-
0038264409
-
Beta 2-microglobulin as a negative regulator of the immune system: High concentrations of the protein inhibit in vitro generation of functional dendritic cells
-
Xie, J., Ying, W., Freeman, M.E., Barlogie, B. Qing, Y. (2003) Beta 2-microglobulin as a negative regulator of the immune system: high concentrations of the protein inhibit in vitro generation of functional dendritic cells. Blood, 101, 4005 4012.
-
(2003)
Blood
, vol.101
, pp. 4005-4012
-
-
Xie, J.1
Ying, W.2
Freeman, M.E.3
Barlogie, B.4
Qing, Y.5
-
170
-
-
0028875568
-
Idiotype-reactive T-cell subsets and tumor load in monoclonal gammopathies
-
Yi, Q., Osterborg, A., Bergenbrant, S., Mellstedt, H., Holm, G. Lefvert, A.K. (1995) Idiotype-reactive T-cell subsets and tumor load in monoclonal gammopathies. Blood, 86, 3043 3049.
-
(1995)
Blood
, vol.86
, pp. 3043-3049
-
-
Yi, Q.1
Osterborg, A.2
Bergenbrant, S.3
Mellstedt, H.4
Holm, G.5
Lefvert, A.K.6
-
171
-
-
0030884240
-
Myeloma bone marrow plasma cells: Evidence for their capacity as antigen-presenting cells
-
Yi, Q., Dabadghao, S., Osterborg, A., Bergenbrant, S. Holm, G. (1997) Myeloma bone marrow plasma cells: evidence for their capacity as antigen-presenting cells. Blood, 90, 1960 1967.
-
(1997)
Blood
, vol.90
, pp. 1960-1967
-
-
Yi, Q.1
Dabadghao, S.2
Osterborg, A.3
Bergenbrant, S.4
Holm, G.5
-
172
-
-
0036243105
-
Optimizing dendritic cell-based immunotherapy in multiple myeloma
-
Yi, Q., Desikan, R., Barlogie, B. Munshi, N. (2002) Optimizing dendritic cell-based immunotherapy in multiple myeloma. British Journal of Haematology, 117, 297 305.
-
(2002)
British Journal of Haematology
, vol.117
, pp. 297-305
-
-
Yi, Q.1
Desikan, R.2
Barlogie, B.3
Munshi, N.4
-
173
-
-
33745125857
-
Intranodal vaccination with idiotype-pulsed dendritic cells induces potent and long lasting cellular and humoral immune responses in myeloma patients
-
Abstract 5277.
-
Yi, Q., Freeman, M.E., Szmania, S., Rosen, N., Cottler-Fox, M., Barlogie, B., Tricot, G. van Rhee, F. (2003) Intranodal vaccination with idiotype-pulsed dendritic cells induces potent and long lasting cellular and humoral immune responses in myeloma patients. Blood, 102 (Suppl. 1 Abstract 5277.
-
(2003)
Blood
, vol.102
, Issue.1
-
-
Yi, Q.1
Freeman, M.E.2
Szmania, S.3
Rosen, N.4
Cottler-Fox, M.5
Barlogie, B.6
Tricot, G.7
Van Rhee, F.8
-
174
-
-
0000343858
-
Recurrent pneumonia in multiple myeloma and some observations on immunologic response
-
Zinneman, H.H. Hall, W.H. (1954) Recurrent pneumonia in multiple myeloma and some observations on immunologic response. Annals of Internal Medicine, 41, 1152 1163.
-
(1954)
Annals of Internal Medicine
, vol.41
, pp. 1152-1163
-
-
Zinneman, H.H.1
Hall, W.H.2
-
175
-
-
33748987908
-
Cancer despite immunosurveillance: Immunoselection and immunosubversion
-
Zitvogel, L., Tesniere, A. Kroemer, G. (2006) Cancer despite immunosurveillance: immunoselection and immunosubversion. Nature Reviews Immunology, 6, 715 727.
-
(2006)
Nature Reviews Immunology
, vol.6
, pp. 715-727
-
-
Zitvogel, L.1
Tesniere, A.2
Kroemer, G.3
-
176
-
-
16844379997
-
Immunosuppressive networks in the tumour environment and their therapeutic relevance
-
Zou W. (2005) Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nature Reviews Cancer, 5, 263 274.
-
(2005)
Nature Reviews Cancer
, vol.5
, pp. 263-274
-
-
Zou, W.1
|